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Abstract
Since the beginning of 20th century, human longevity has been increasing tremen-
dously. The growth of ageing population is evidence for positive milestones of
a society’s well-being. Apparently, socio-economic status is commonly concep-
tualised as a social standing of an individual or society. Higher socio-economic
status has long been identified as a contributing factor for mortality improvement.
The ongoing increases of ageing population have alarmed many organisations es-
pecially pension fund providers and insurance companies offering annuities and life
insurances. Furthermore, the evolution of longevity is believed to produce a new
curve on the standard life expectancy as its shift has underestimated the future
life expectancy. The purpose of this study is to develop a robust mortality model
factoring the macroeconomic element. It is motivated by the evolution of longevity
that causes insufficient to pension and annuities funding, inaccurate estimation of
life tables, under-pricing of financial products and under-estimation of longevity
risk.
First, this study extents the works from previous mortality models, in particular
O’Hare-Li (OL) model, by considering the influencing factor of Gross Domestic
Product (GDP) into the new model. Hence, the development of the new model
(OL-GDP) is through the combination of OL model and the GDP-age dependent
factor. The OL-GDP model is then applied to the selected Eurozone countries.
The results show that central mortality rates estimated by OL-GDP are robust
and have better fitting relative to alternative models.
Second, this study analyses the robustness of the OL-GDP model given various
changes in its parameters. Sensitivity analyses are conducted to study the impact
of the model towards various modifications of each parameter. The study is then
extended on analysing its impact on insurance pricing and reserving through the
calculations of the Actuarial Present Values (APVs) of life insurance and annuity
products. Undoubtedly, OL-GDP model maintains its robustness given changes
in various parameters on most actuarial products as compared to other mortality
models under study.
Thirdly, as for risk management measures, this study demonstrates the approach
of natural hedging between two portfolios, annuity and life insurance. This ap-
proach is more suitable for a company that underwrites both businesses, life and
annuity. The management of the liability outflows can be done internally within
the company. Evidently, the application of the natural hedging within a com-
pany, provides stability of the company’s outflows and better management of its
insurance liabilities. In addition, this study introduces an alternative risk transfer
tool for managing longevity by issuing longevity bond. Hence, this study proposes
methods of structuring and pricing a longevity bonds as an alternative risk transfer
tool for managing longevity risk.
The contribution to the academic literature is threefold. On the theoretical side,
building on the work of existing mortality models, this study proves that macroeco-
nomic factors have significant influence on mortality models. On the empirical side,
the OL-GDP model has higher sensitivity towards insurance pricing and reserving
as compared to alternative models. Moreover, the OL-GDP model maintains its
robustness to variations within the parameters of the model.
Generally, the OL-GDP model successfully reproduces better mortality estima-
tions for a significant number of Eurozone countries. Moreover, OL-GDP provides
more plausible forecasts that may assist insurers and pension providers to improve
their insurance pricing and reserving strategies. Finally, due to its robustness,
this model is reliable to help in improving a company’s risk management frame-
work in managing its insurance liabilities of life and annuity portfolios efficiently.
What is more, as an alternative risk transfer tool, this study proposes methods
for structuring and pricing the longevity bond.
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Chapter 1
Introduction
The evolution of human longevity has been made significant ever since the be-
ginning of the 20th century. Many industrialised countries witnessed a consistent
rising of human longevity at a promising growth. Factors like socio-economic
status, medical innovations, nutrition habits and environmental conditions are be-
lieved to be the contributing aspects (French and O’Hare, 2014; Gaille and Sherris,
2010). Each country experiences a different trend of longevity improvement. For
instance, the life expectancy for European countries has risen significantly over the
past few decades. This has led insurance and pension providers to revisit their way
to price their products and to hedge the longevity risk. The key to this exercise
is to have a robust mortality model.
1.1 Background of the Study
Life expectancy is one of the most important indicators used to compare differ-
ent population groups in demography studies. Statistically, it is defined as the
mean number of years a cohort of people might expect to live based on the year
of birth, current age and other factors including sex. The ongoing increases of life
expectancy followed by the significant increase of ageing population have alarmed
many organisations especially pension providers such as governments, pension
funds, and insurance companies offering annuities and life insurances (Bloom et al.,
2007; Hari et al., 2008; Pitacco et al., 2009). It is believed that the evolution of
this longevity trend has produced new curves to the standard life expectancies,
making the current life tables underestimate the future life expectancy.
1
2The government faces challenges on financing older people with longer life spans
whilst insurers are liable for providing conducive and appropriate health care so-
lutions sufficiently. In response to these concerns, the issue of longevity risks must
be well addressed by the related bodies. This is to ensure that governments fund
the pension system sufficiently, and actuaries and insurers price their age-related
financial instruments appropriately.
In a similar way, the premise of this thesis is about the issue of longevity risk.
Due to the under-estimation of current life tables, this study developed a new
mortality model for the selected Eurozone countries. As the potential reasons for
mortality improvements comprise of socio-economic status, technological advance-
ment in medicine, nutrition and diet, lifestyle, and living environment (Gaille and
Sherris, 2010; Roy, 2012; French and O’Hare, 2014), this study utilises the factor
of economics impact, GDP, in modelling the new mortality model. The model,
OL–GDP (extended model of O’Hare and Li (2012)), is then being used for all
other studies in this thesis. The robustness of the model is compared against
other mortality models namely Lee and Carter (1992) model (LC), O’Hare and
Li (2012) model (OL) and Niu and Melenberg (2014) model (LC-GDP), as this
model incorporates the GDP factor into the LC model.
Subsequently, this study analyses the model’s stability by observing variations
within the parameters of the model. Variations in age range, correlation coef-
ficients, age parameter, time dependent factor k2t and forecasting methods are
among the factors analysed in this study. In addition, this study investigates the
impact of insurance pricing and reserving in respect to related various changes
within the Actuarial Present Values (APVs) calculations. This includes variations
of mortality models, forecasting methods and interest rates.
Nevertheless, in mitigating the issue of longevity risk, this study undertakes the
concept of natural hedging that applies within a company. This internal approach
optimises the allocation of annuities and term insurance corresponding to mortality
improvement and deterioration. Moreover, this study proposes the next step of
hedging the longevity risk by issuing a longevity bond. The framework of this
approach is based on Lorson and Wagner (2014), where the most important parts
in pricing the bond are defining the tranche and excess loss process, and the
computations of principal payment and coupon payment.
31.2 Problem Statement
Considered as one of the positive drives in raising the society’s well-being, socio-
economic status is said to have a significant impact on the mortality improvements
for some countries. Factors conducive to mortality improvement vary for each
country, thus, each country experiences a different trend of mortality improvement
(Roy, 2012). For instance, the life expectancy for European countries has risen
significantly over the past few decades. This has led the insurance and pension
providers to revisit the way their price the products and hedge the longevity risk.
The key to this exercise is to have a robust mortality model.
The evolution of longevity is believed to produce a new curve on the standard life
expectancy. Apparently, this shift has underestimated the current one. Therefore,
an accurate measure of estimating the future life expectancy is deemed crucial for
holders of longevity risks like pension funds, life insurers and annuity providers.
They need to be more mindful of funding, pricing and reserving their products
sufficiently. On another development, evidence of macroeconomic impact on mor-
tality has been presented by many researchers (Preston, 2007; Granados, 2008;
Hanewald, 2011; Niu and Melenberg, 2014; Rolden et al., 2014; Boonen and Li,
2017). These findings lead to a new endeavour of exploring this relationship. This
study takes a step forward on improving the existing mortality rates by considering
the influence of a macroeconomic factor, namely GDP.
Knowing that some important parameters in the mortality model are sensitive to
the direction of future mortality rates, this study analyses the reactions of the mor-
tality rate estimations given variations in the model’s parameters. Furthermore,
even small changes in mortality rates may have an impact on the age-related fi-
nancial instruments like annuity and life insurances. Thus, a comprehensive study
on how to arrive at the most optimum price that ensures sufficiency is essential.
For this reason, this study provides a number of quantifying ways on the impact
of these variations on various financial calculations.
As part of the risk management framework in mitigating longevity risk, various is-
sues pertaining to pricing and reserving the insurance and annuity products have
increasingly become major challenges. Natural hedging is considered as a self-
managed risk, executed internally within the company. This execution is more
appropriate for a company that writes both life insurance and annuity businesses.
Natural hedging benefits the company through stabilising its liabilities outflow.
4Companies can reduce their liabilities if both businesses are being transacted con-
currently. Nevertheless, striking a balanced business portfolio is difficult because
of the demand and supply rule. The portfolio between life insurance and annuity
may not always be balanced. Therefore, as part of an alternative risk transfer
tool, transferring risks to financial markets is seen to be efficient in pooling the
risk for hedging longevity successfully. Structuring and pricing longevity risk using
modern securitisation methods, has become a heuristic and provided avenues for
researchers to explore further. This study considers the securitisation of longevity
risk focusing on structuring and pricing a longevity bond using techniques devel-
oped by Lorson and Wagner (2014) and Kim and Choi (2011). A model based on
Eurozone countries mortality data and calibrated to insurance risk linked market
data is used to assess the structure and market consistent pricing of a longevity
bond.
1.3 Research Aims and Objectives
This study aims to develop a robust mortality model considering the influential
macroeconomic factor of gross domestic product (GDP). The research objectives
are as follows:
1. To find the best model fitting the mortality rates for the selected Eurozone
countries;
2. To analyse the sensitivity of the insurance pricing and reserving given changes
on the model parameters; and
3. To examine the impact of mortality risk and propose a framework of struc-
turing longevity bonds as part of mortality risk management.
1.4 Significance of the Study
Despite the growing interest in mortality and longevity, there are few empirical
studies that examine the application of these risks on the insurance pricing and
risk management framework. Having said that, numerous attempts have been
5applied to model mortality experience. However, the application of GDP in mor-
tality rate is considerably new. Thus, this study offers two-prong evidences. On
the theoretical side, factoring GDP helps to improve the robustness of existing
mortality models. On the other hand, new empirical evidence suggests that the
GDP-related model results in better insurance pricing as compared to other models
and the longevity risk can be hedged with securitisation.
Evidently, with the inclusion of GDP growth indicator in the OL model, this study
finds the best fitting model for most Eurozone countries, especially for France,
Germany and Italy. Except for female, male and unisex produced the best fitting
of OL-GDP as compared to other models. This study notes the impact of GDP is
significant especially for the most populous countries. What is more, the proposed
model also demonstrates better quality forecasts of mortality rates through the
applications of ARIMA process and Exponential Smoothing techniques.
Essentially, the Mean Absolute Percentage Error (MAPE) measures of forecasting
shows a significant improvement in forecasting results for shorter (5 years) and
longer (15 years) period of times in comparison to the LC model which acts as the
reference model. Hence, the impact of economic growth on mortality dynamics
has proved to be noteworthy. Further investigation on this will certainly give some
light on mortality studies. An in-depth study on this will absolutely give clearer
direction on this relationship, explain the mortality trends precisely, and at the
same time improve the mortality forecasting accuracy.
In addition, this study considers the impact of insurance and annuity pricing on
the GDP-related mortality model. Reflecting the variations and range of modi-
fiable factors involved in the model, the analysis shows that generally, OL-GDP
model generates better results relative to other models on the actuarial present val-
ues (APVs) calculations. APVs are typical calculations for obtaining appropriate
amounts for benefit-payment or series of payments associated with life insurance
and life annuities. Factors like choice of data period and forecasting methods, also
variations of correlation coefficients, interest rates, age groups and age parameters
have been considered in assessing their impact on pricing the insurance products.
Sufficient reserves are crucial for all regulated insurers as they are required to keep
aside reserves for managing future liabilities. Reserves play an important role in
assessing the financial condition of an insurer. Reserves are also important in
assessing the solvency of an insurer, in terms of its ability to meet its liabilities.
6Moreover, reserves are also important in pricing the insurance products more ac-
curately. Actuaries price the insurance products by estimating the future cost of
claims on risks yet to be paid off to the insured by extrapolating the past paid
and reserved claim cost.
Furthermore, this study contributes to the current discussion about how insurers
can hedge the longevity risk naturally and internally within their insurance and
annuity portfolios. Natural hedging aims to stabilise the liabilities outflow of the
insurer. Insurer may reduce its mortality risks if both insurance and annuity busi-
ness are transacted concurrently. On the other hand, as an alternative to natural
hedging, this study has introduced another approach of hedging the longevity risk.
The longevity risk can also be transferred to other platforms like financial markets.
The act of transferring the risks of the porfolio to the third party is called securiti-
sation. Following this, this study has introduced longevity bonds. The framework
on how this bond is being structured and priced, is being discussed accordingly.
1.5 Research Questions
The mortality rates are not static and they have been influenced by various factors
like lifestyle, biophysical, environment and macroeconomic factors. The latter
have the most impact in socio-economic terms. Therefore, macroeconomic factors
like the gross domestic product (GDP) have the greatest influence since they are
also closely related to other factors such lifestyle, physical well-being and the
surrounding environment.
With that, this study would like to understand the level of influence that GDP
has on mortality rates. Thereafter, understanding the impact that the adjusted
mortality rate has on insurance pricing and reserving as well as measuring mortal-
ity risk in respect to improvement and deterioration in mortality rates. Moreover,
how the insurers and pension providers manage insurance liabilities given changes
in mortality rates in the future. The above can be answered by addressing the
research questions in achieving the thesis’ aims and objectives.
71. How does the new model improve the estimation of central mortality rates
and its forecasting power?;
2. How does the new model respond to variations in parameters for sensitivity
of insurance pricing, reserving and insurance liabilities?; and
3. How to hedge the mortality risk such as longevity risk for life insurance and
annuity portfolios?.
1.6 Research Design
In meeting those research objectives, this study conducts quantitative time-series
analysis. First, model estimation and fitting as well as testing. Second, model
testing for the insurance pricing sensitivity. Third, structuring and pricing the
longevity risk with securitisation.
More specifically, this thesis is structured as follows. First, this study focuses
on the nine most populated Eurozone1 countries and analyses the effect of socio-
economic factors on mortality trends. Namely, this study considers Austria, Bel-
gium, Germany, Greece, France, Italy, the Netherlands, Portugal and Spain. This
study grouped these countries into two categories, the strong economic countries
like Austria, Belgium, Germany, France and the Netherlands (these countries are
long known to hold strongest economic position nationally, while keeping their
momentum high by joining Eurozone); and the crisis countries like Greece, Italy,
Portugal and Spain (these countries suffered economically and were unable to
repay or refinance their government debts following the global crisis in 2008).
Second, this study examines the impact of the new model on its ability to forecast
the mortality rates if the parameters involved in the model are modified. Further
analysis would also be conducted to study each parameter’s sensitivity against the
model. Subsequently, the next focus of this study is to demonstrate each param-
eter’s impact on pricing and reserving the annuity and insurance products. The
1The Eurozone was established on 1 January 1999 with its first members of 11 countries. It
was then enlarged to 19 countries namely Austria, Belgium, Cyprus, Estonia, Finland, France,
Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Por-
tugal, Slovakia, Slovenia and Spain. These 19 countries are out of the 28 European Union (EU)
member states that are grouped together within the same monetary union, using the Euro (e)
as their common currency and sole legal tender. The monetary authority of the Eurozone is
called Eurosystem.
8new model allows for simple quantitative measures of those parameters in con-
nections to mortality forecasts. This is crucial in developing long-term mortality
projections, which an important issue in life insurance and pensions.
Third, this study introduces a model for annuity securitisation with the help of
longevity bond. At the same time, this study has taken the perspective of the
issuing insurer and calculated the price of hedging for the company. This study
applied a tranching approach for the securitisation based on the percentile tranch-
ing method and designed the securities in a way that the principal payments
are risky, i.e. depend on the survival rates of the underlying portfolio of annui-
tants. To do so, this study first used the OL-GDP model for European countries
and calculated estimates on future mortality rates. Next, the tranching process
is grouping the portfolio into different rated tranches according to different risk
profiles as suggested by S&P ratings for insurance-linked securities. Finally, this
study determined the price of the longevity bond for hedging the contracts against
longevity risk.
1.7 Overview of the Thesis
The following chapters in this thesis are structured as follows. Chapter 2 explains
the macroeconomic factor of GDP that influences mortality rates and the estab-
lishment of a new GDP-related mortality model. Thereafter, based on the new
GDP-related mortality model, insurance pricing and reserving impact are anal-
ysed in Chapter 3. Subsequently, the new GDP-related mortality model is further
applied in Chapter 4 for examining the mortality risk and structuring longevity
securities. Chapter 5 concludes this thesis.
In Chapter 2, an introduction starts in Section 2.1, expectation, explanation and
extrapolation of life expectancy are discussed in Section 2.2. Whereas, Section 2.3
briefly reviews the main mortality models and this study further investigates the
relationship between economic growth (GDP) and mortality rates. Section 2.4
focuses on the statistical analyses of the data for the nine Eurozone countries (in
our study, Austria, Belgium, France, Germany, Greece, Italy, the Netherlands,
Portugal and Spain), derived from the Human Mortality Database (HMD), fol-
lowed by a descriptive analyses of the long run relationship among time series
data using the Johansen (1988) co-integration test, and other various correlation
9tests. Based on the findings and comparison studies, this study proposes a new
GDP-related model in Section 2.5, with detailed discussion of the fitting process.
The forecasting performance using ARIMA process and Exponential Smoothing
is discussed in Section 2.5. Finally, Section 2.6 concludes the whole discussion of
the study.
Chapter 3 is organised as follows. An introduction is discussed in Section 3.1.
Section 3.2 presents an analysis of the impact of various factors involved in the OL-
GDP. Based on the outcomes of Section 3.2, the sensitivity analyses are presented
in Section 3.3. This section presents the impact of insurance pricing for selected
actuarial products given changes of parameters on the OL-GDP model and other
mortality models under study.Section 3.4 presents the results of actuarial reserve
for selected actuarial products. Finally, Section 3.5 concludes the whole discussion
of this chapter.
Chapter 4 is organised as follows. An introduction is discussed in Section 4.1.
Section 4.2, demonstrates the idea of natural hedging that can be done internally
within the company. Section 4.3 analyses the economics of mortality risk and the
needs for mortality securitisation. Section 4.4 proposes the mortality securitisation
framework for annuity portfolio by introducing a longevity bond. Section 4.5
concludes.
Lastly, Chapter 5 concludes this study by showing the robustness of the OL-
GDP model together with empirical testings. In addition, Chapter 5 presents the
limitations of the work done and proposed directions for future research. Finally,
this study recommends areas for applying and extending the OL-GDP model in
future studies.
1.8 Conclusion
A change in mortality rate experience has become a serious concern for insurers
and pension providers. Hence, better life expectancy has led to underestimation of
future life expectancy. Consequently, this has caused deficits in pension funds for
instance. Having a robust mortality robust helps insurers and pension providers
manage their mortality risk more prudently. However, the challenge of modifying
mortality projections is made more interesting since the mortality improvements
are not comparable across all countries. Some studies have found that different
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countries experience different stages of demographic transition due to different pat-
terns of population growth. This scenario can be clearly observed when comparing
developed and emerging countries. Thus,an accurate identification of factors af-
fecting the mortality experience in a particular country is crucial. On the other
hand, evidence of a relationship between economic changes and mortality in many
developed and developing countries has been presented by many researchers.
Against this background, this study aims to develop a new mortality model that
considers the influences of macroeconomic factors like growth in gross domes-
tic product (GDP) for the nine most populated Eurozone countries and analyse
the effect of socio-economic factors on mortality trends. The selected countries
are Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Portugal and
Spain. Data from 1960 to2007 (except: Germany: 1970–2007, Greece: 1981–2007).
In achieving the goal, this study focuses on three research objectives. First, this
study analyses the relationship between GDP and mortality rate as well as its
robustness in the nine countries. This study validates the proposed model with
several approaches like MAPE, MAD and BIC analysis, and investigates the good-
ness of fit of all alternative models, i.e. Lee and Carter (LC), O’Hare and Li (OL),
LC-GDP and OL-GDP. Second, it further examines the impact of the new mor-
tality towards insurance pricing and reserving. Third, to investigate the insurers
and pension providers’ cash flow sensitivity given the improvement/deterioration
in mortality rate.
In meeting those research objectives, this study conducts a quantitative time-series
analysis. First, by improving the existing model with GDP for model regression
and fitting as well as statistical testing. In addition the new model is tested
with forecasting capability in determining its accuracy relative to the alternative
models commonly referred in academic studies. Second, the model is statistically
tested for insurance pricing and reserving impact to the insurers and pension
providers. Third, conducting sensitivity analysis on improvement or deterioration
in mortality rates that leads to structuring and pricing of the longevity risk with
securitisation, for instance, longevity bond.
The importance of this study can be three pronged. On the theoretical perspective,
this study improves the existing mortality models by considering the influence
of macroeconomic factor that best explain the socio-economic trends in selected
Eurozone countries. As for the empirical side, this study shows better capabilities
of the model in analysing the impact of insurance pricing and reserving relatives
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as compared to the existing models. Lastly, this study helps insurers and pension
providers respond to the change (improvement or deterioration) in mortality rates.
The changes have put a great impact on cash flows and liabilities to the insurers
and pension providers. Therefore, the key is to have a robust mortality model
that works across countries.
Chapter 2
Life Expectancy with OL-GDP
Model
Socio-economic status is commonly conceptualised as the social standing or well-
being of an individual or society. Higher socio-economic status has long been
identified as a contributing factor for mortality improvement. This paper stud-
ies the impact of macroeconomic fluctuations with GDP as a proxy on mortality
for the nine most populous Eurozone countries. Based on the statistical analysis
between time-dependent indicator of Lee and Carter model and GDP, and adap-
tation of the good features of the O’Hare and Li model, a new mortality model
including this additional economic-related factor is proposed. Results for male and
female from ages between 0–89, and similar for unisex data are provided. This
new model shows a better fitting, and more plausible forecasts among a significant
number of Eurozone countries. An in-depth analysis of the findings is provided
to give a better understanding of the relationship between mortality and GDP
fluctuations.
2.1 Introduction
Since the beginning of the 20th century, human longevity has been increasing
tremendously. The growth of ageing population is evidence for a positive milestone
of society’s well-being. Each country experiences a different trend of longevity
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improvement (Pampel, 2005; Yang and Wang, 2013). For instance, the life ex-
pectancy for European countries has risen significantly over the past few decades
as shown in Figure 2.1. Life expectancy rose by 14 years from 1950 to 20151.
Figure 2.1: European Life Expectancy at Birth for Male, Female and Overall
Many academics, Yang et al. (2010), Deng et al. (2012) and D’Amato et al. (2014),
among others, discuss improvements in life expectancy. This reflects that people
are living much healthier and better now as compared to previous generations. Ac-
cording to Gaille and Sherris (2010); Roy (2012); and French and O’Hare (2014),
some potential reasons for these improvements may be socio-economic status, mar-
ital status, technological advancement in medicine, nutrition and diet, lifestyle and
living environment. The increases in life expectancy are mainly due to improve-
ment in the food supply, sanitation, technology, basic healthcare and education
(Roy, 2012). It is believed that the evolution of the trend in longevity has pro-
duced a new curve to the standard life expectancy, making current life tables
underestimate future life expectancy (Barrieu et al., 2012). This phenomenon has
become more crucial since it has drawn the attention of many organisations like
pension funds, life and health insurers and individuals.
Holders of longevity risk, particularly now need to be more mindful of their funding
and price methods to ensure their products are priced and reserved for sufficiently
(Richards and Currie, 2009; Seklecka et al., 2017a). The government faces chal-
lenges on financing an ageing population with longer life spans whilst the insurers
1Source: United Nations Department of Economic and Social Affairs / Population Division
World Population Prospects: The 2015 Revision, Volume II: Demographic Profiles.
14
liable for providing conducive and appropriate healthcare solutions need to under-
stand expected lifetimes sufficiently. The threats of longevity risk also extend to
individuals where they have not, or are unable to purchase products that insure
their retirement income. Eventually, the longevity phenomenon will affect the
annuity values, pensions, insurances and individual savings (Richards and Cur-
rie, 2009; God´ınez-Olivares et al., 2016; Seklecka et al., 2017a). Thus, the need to
model mortality more accurately becomes critical in planning for one’s sustainabil-
ity. It helps the government in funding pension policies sufficiently, actuaries and
insurers in pricing age-related financial instruments appropriately and individuals
in planning their post-retirement favourably.
The challenge of modifying mortality projections is made more interesting since
the mortality improvements are not comparable across all countries. Roy (2012),
in his study, found that different countries experience different stages of demo-
graphic transition due to different patterns of population growth. He further
commented that this scenario can be clearly observed when comparing the devel-
oped and emerging countries. Thus, an accurate identification of factors affecting
the mortality experience in a particular country is crucial. On the other hand,
evidence of a relationship between economic changes and mortality in many devel-
oped and developing countries has been presented by many researchers (Preston,
2007; Granados, 2008; Hanewald, 2011; Granados and Ionides, 2011; Hanewald
et al., 2013; Niu and Melenberg, 2014; Rolden et al., 2014; Boonen and Li, 2017).
This study analyses the effect of socio-economic factors on mortality trends for
selected Eurozone countries namely, Austria, Belgium, Germany, Greece, France,
Italy, the Netherlands, Portugal and Spain. These countries are considered in this
study not only because they are members of the same monetary union, but also due
to their populations exceeds 10 million citizens.2 According to Chen et al. (2017),
small population is bias in modelling mortality stochastically. Empirical research
has found that mortality rates of smaller populations exhibit significantly more
variability compared to the observed rates in larger populations. Another related
issue is that empirical data from smaller populations might only be available for a
relatively short period, which makes mortality projections rather uncertain. As a
result, this study focuses on the Eurozone countries that have a significant number
of the population size.
22011 census.
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Additionally, the majority of these countries has shared common monetary and
fiscal policies for the last 40 years (even before being members in the Eurozone sys-
tem), and also due to their co-dependent and homogeneous growth cycles (Chen
and Mills, 2009). Despite having an overall competitive economic growth per-
formance, different countries in Eurozone experience different pace of economic
growth. Countries that have significant economic growth are mainly those located
in central Europe like Austria, Belgium, Germany, France and the Netherlands.
Whilst gradual growth is experienced by those representing the peripheral ones
like Spain, Greece, Italy and Portugal.
One of the main goals of this study is to examine the relationship between trends
in mortality and trends in GDP change (as a proxy for economic fluctuations). In
this direction, a study conducted by Niu and Melenberg (2014) gave impetus to us
to extend it on the selected Eurozone countries. First, we explore the relationship
between the time-dependent factor of the Lee and Carter (1992) model k1t , and the
logarithm of GDP for males and females aged between 0 to 89 (similar for unisex
data). Then, this study investigates the long run relationship and correlation
between these factors using Johansen (1988) co-integration test. Additionally, this
study examines the correlation between both factors using appropriate correlation
tests. For instance, Pearson (1895)’s correlation coefficient test shows that there
is a long-run relationship between the mortality index and GDP as we observe a
strong negative correlation between them. The findings from these tests provided a
strong foundation and motivation to investigate this relationship further. Finally,
we introduce a new stochastic central mortality rates model by modifying O’Hare
and Li (2012) model (hereafter referred to as the OL) through the implementation
of an additional GDP-related factor capturing the effect of economic fluctuations
on mortality.
Forecasting mortality rates is a natural application of our approach. As in previous
studies (Niu and Melenberg, 2014; Seklecka et al., 2017a,b), among others, our
forecasting methodology is a combination of the explanation and extrapolation
methods (Booth and Tickle, 2008) (see Section 2.2 for more details). Analytically,
the real GDP per capita is included as an observable factor, which captures the
correlation between long-term trends in mortality dynamics and economic growth.
The trend in mortality rates is captured and the future mortality rates are based
on historical trends.
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The remainder of this chapter is organised as follows. Expectation, explanation
and extrapolation of life expectancy are discussed in Section 2.2. Whereas, Section
2.3 briefly reviews the main mortality models and this study further investigates
the relationship between economic growth (GDP) and mortality rates. Section
2.4 focuses on the statistical analyses of the data for the nine Eurozone countries
(in our study, Austria, Belgium, France, Germany, Greece, Italy, the Netherlands,
Portugal and Spain), derived from the Human Mortality Database (HMD), fol-
lowed by a descriptive analyses of the long run relationship among time series
data using the Johansen (1988) co-integration test, and other various correlation
tests. Based on the findings and comparison studies, this study proposes a new
GDP-related model in Section 2.5, with detailed discussion of the fitting process.
The forecasting performance using ARIMA process and Exponential Smoothing
is discussed in Section 2.6. Finally, Section 2.6 concludes the whole discussion of
the approach.
2.2 Expectation, Explanation and Extrapolation
of Life Expectancy
Rapid increases in life expectancy have increased the desire and need to study mor-
tality. As changes in mortality experience is not comparable across all countries, a
dynamic approach that can accurately describe the changes is essential. Accord-
ing to Booth and Tickle (2008), mortality forecasting can be divided into three
categories; expectation, explanation and extrapolation. The expectation approach
is based on the subjective opinions of experts, the explanation approach is derived
from certain causes of death with known determinants whilst the extrapolation
approach makes use of the regularity found in age patterns and trends over time.
It estimates the future mortality using the current mortality rates and estimates
the rate of change of future mortality by observing patterns in past changes. Most
of the models in the literature are based on the extrapolation method.
2.2.1 Extrapolative Mortality Modelling
The evolution of mortality studies has started a few centuries ago. A number of
pioneering works were carried out as early in the 15th century. In 1693, a famous
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astronomer, Edmond Halley developed the first life table based on applications to
life contingencies. Subsequently, in 1725, Abraham De Moivre proposed the first
mathematical formula of mortality modelling.
lx = k
(
1− x
86
)
, for 12 ≤ x ≤ 86 (2.1)
where lx is the number of individuals still alive at age x last birthday from an
original pool, l0 of individuals, and k is a constant. He assumed that all individuals
must die before the age of 86. For more details, please see Bowers et al. (1997).
A century later, Gompertz (1825) proposed the new mortality law in 1825. Theo-
retically, the Gompertz’s idea on the term of force of mortality can be accurately
expressed in the model. Denoting the force of mortality by µx, Gompertz’s law is
as follows:
µx = α exp (βx) (2.2)
where α and β are positive parameters and x denotes the age3. More discussions
about mortality laws can be found in Bowers et al. (1997). What is more, Heligman
and Pollard (1980) proposed a class of formulae which aimed to represent the age
pattern of mortality over the whole span of life4.
Over 160 years later and with advances in computing techniques, Lee and Carter
(1992) proposed the new mortality model that has been widely accepted and re-
ferred to in mortality studies. They remarkably proposed a simple stochastic
model reflecting the reduction of the annual log age-specific death rates through
a time-dependent index,
ln(mx,t) = b
1
x + b
2
xk
1
t + x,t (2.3)
where mx,t is the central death rate, the ratio between the number of people aged
x who died in year t, and the exposure to risk of the average population aged x
in year t. Factor b1x describes the average age-specific mortality, that ensures the
basic shape of the mortality curve over ages is in line with historical observations,
3By focusing on the old ages, Gompertz (1825) has weakened the model by not representing
the mortality over the whole lifetime span.
4Heligman and Pollard (1980) proposed a sum of three terms representing different compo-
nents of mortality:
m(x) = A(x+B)
C
+DeE(ln x−lnF )
2
+
GHx
(1 +GHx)
,
where A,B, ...,H are parameters to be estimated.
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factor k1t represents the changes in the mortality level, whilst factor b
2
x describes
the decline in mortality at age x. It explains how rapidly/slowly mortality rates
decline in response to k1t . The error term at age x and time t, is x,t. The LC
model describes the smooth and gradual decline of mortality rates over time. This
has become debatable as the variance of mortality rates exponentially grows in
time. Following the LC model, a series of extensive studies were conducted by
many researchers including Lee and Miller (2001), Booth et al. (2002), Renshaw
and Haberman (2006), Hyndman and Ullah (2007), Cairns et al. (2009, 2011),
Plat (2009), O’Hare and Li (2012) building on the extrapolation approach and
improving the mortality modelling.
To be more precise, Renshaw and Haberman (2006) modified the LC model by
adding a cohort effect parameter into the formula:
ln(mx,t) = b
1
x + b
2
xk
1
t + b
3
xγt−x + x,t (2.4)
where γt−x models the cohort effect. Their model provides a better fit to the
historical data, where the cohort effect was observed in the past in a particular
country with the best results for b3x = 1. However, this model suffers from lack
of robustness and has a trivial correlation structure (Cairns et al., 2009, 2011).
Notwithstanding this criticism, Haberman and Renshaw (2011) then conquer this
argument by justifying that issues observed in these studies were a result of the
fitting procedure used to obtain parameter estimates. This statement has also
been confirmed in a more recent paper by Hunt and Villegas (2015).
Particularly, Cairns et al. (2006b) proposed a two-factor model of mortality:5 Sub-
sequently, in their extended research using data from England and Wales, and
United States, they observed that the fitted cohort effect appears to have a trend
in the year of birth. This suggested that the cohort effect compensates for a lack
of a second age-period effect as it attempts to capture the cohort effect from the
data. Hence, in 2009, Cairns et al. improved the the two-factor model by adding
5Cairns et al. (2006b):
log(
qx,t
1− qx,t ) = k
1
t + (x− x¯)k2t + x,t,
where qx is the probability that a person aged x dies within the next year (qx,t ≈ 1 − e−mx,t),
x¯ is the mean age in the sample range and (k1t , k
2
t ) are assumed to be a bivariate random walk
with drift.
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the second age cohort effect. This improvement captures the cohort effect as an
additional effect on top of the two-factor (age and period) effects.
Following this, Plat (2009) incorporated the cohort and age-period effects6 to the
LC model. His model provides significant and better results since it implies the
importance of younger ages in modelling the mortality experience of a population.
Subsequently, O’Hare and Li (2012) extended the Plat (2009) model by adapting
the non-linear profile of mortality at lower ages:
ln(mx,t) = b
1
x + k
1
t + (x¯− x)k2t +
(
(x¯− x)+ + ([x¯− x]+)2)k3t + γt−x + x,t (2.5)
where k2t factor allows changes in mortality to vary between ages reflecting the
historical observation that improvement rates can differ for different age classes,
k3t models the effects specific to the lower ages, γt−x models the cohort effect,
(x¯ − x)+ = max(x¯ − x, 0), and x¯ is the average of age considered. Their model
provides a better fit for the range of countries considered and shows flexibility to
fit the mortality rates of a wider range of ages. What is more important, this
model does not lose any of the benefits of the previous stochastic models.
The number of wide-ranging mortality studies has increased significantly due to
the rapid increase of longevity and the need to better understand it. That increase
in all age-intervals is primarily due to several factors such as socio-economic, med-
ical improvements, lifestyle, living environment, climate change and many oth-
ers (Granados, 2008; Granados and Ionides, 2011; Hanewald, 2011; French and
O’Hare, 2013, 2014; Niu and Melenberg, 2014; Cairns et al., 2016; Seklecka et al.,
2017b). Socio-economic factor has been discussed and agreed widely as one of
the important factors that affect longevity (Bhargava et al., 2001; Batchvarov and
Gakwaya, 2006; Renton et al., 2012; Preston, 2007; Granados, 2008; Granados
and Ionides, 2011; Hanewald, 2011). According to the Institute and Faculty of
Actuaries (IFoA), as socio-economic status increases, the life expectancy is also
increases. Among other things, socio-economic status can affect a person’s ability
to access adequate medical care and participate in healthier lifestyle habits like
exercising more, smoking less and maintaining a healthy weight.
6Plat (2009) model specification is given by
ln(mx,t) = b
1
x + k
1
t + (x¯− x)k2t + (x¯− x)+k3t + γt−x + x,t,
where (x¯− x)+ = max(x¯− x, 0), and x¯ is the average of the ages considered.
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In accessing the growth of economics and identifying long-term trends in a partic-
ular country, factors like GDP, unemployment rate, income and wages, consumer
price index, currency strength and interest rates are among those indicators that
being studied in observing how the economy changes over time. These indicators
are also known as lagging indicators, reflect the economy’s historical performance
and changes. These indicators are only identifiable after an economic trend or
pattern has already been established. Among these indicators, changes in GDP
has been widely used by many economists in measuring the economy’s current
health in a particular country. When GDP increases, it is a sign the economy is
strong. Moreover, GDP is a key determinant to most businesses as to decide and
adjust their expenditures on inventory, payroll, and other investments based on
GDP output.
This study analyses GDP as one of those influencing factors that affect mortality.
This study employs a correlational studies between GDP and mortality. Corre-
lational studies is more important and useful than other methods as it can be
widely used for many variables especially for variables that cannot be simply ma-
nipulated for ethical reasons like human malnutrition. Additionally, as this study
involves with variables that definitely cannot be manipulated like birth, sex and
age, thus the application of correlational studies is deemed appropriate as the
scientific knowledge concerning them must be based on correlation evidence.
2.2.2 Economic Growth and Mortality Rates
Economic growth and health status are two major factors being deeply studied
in gauging nations’ social development and public policy. Socio-economic factors
such as GDP, inflation and unemployment have clearly been observed to have a
causal effect on mortality experience. The majority of the related studies showed
that the improvements in mortality have been accompanied by growth in GDP.
Bhargava et al. (2001) claimed that there was a positive effect between adult
survival rates and GDP growth rates for low-income countries. Renton et al.
(2012) claimed that GDP makes a contribution to changes in health indicators
through GDP growth and the increased elasticity of health indicators with GDP
over time. While Preston (2007) suggests that in the long run, higher economic
output results in lower mortality.
21
On the other hand, Granados (2008); Granados and Ionides (2011); Granados
(2012) conducted various studies related to macroeconomic fluctuations and mor-
tality. Granados (2008); Granados and Ionides (2011) studied correlations of GDP,
unemployment, and the labour force participation ratio with crude, age-and-sex
specific and cause-and-sex specific mortality rates in postwar Japan and contempo-
rary Sweden. Subsequently, Granados (2012) studied economic growth and health
progress in England and Wales, and found that there was a negative relationship
between economic growth and life expectancy at birth.
In the meantime, Hanewald (2011) investigated the effects of macroeconomic fluc-
tuations and trends in the causes of death on the period effect k1t in the LC model
based on the data for six OECD countries (Australia, Canada, Japan, the Nether-
lands, the United Kingdom, and the United States) over the period of 1950–2006.
Analysis presented in the paper shows that the time-dependent indicator corre-
lates significantly with macroeconomic fluctuations. The results also indicate a
reduction of the mortality index when the economy strengthens. Further analysis
found that these correlations were more significant from a long-run period effect.
Following this, Niu and Melenberg (2014) adopted the idea to study the relation-
ship between latent factors in mortality and macroeconomic variables, based on
the data for six industrialised countries, the United States, the United Kingdom,
the Netherlands, Canada, Australia, and Japan over the period of 1950–2007. As
a result of their investigation, a new mortality model was proposed. Niu and Me-
lenberg (2014) incorporated the economic factor (real GDP per capita as proxy)
in their extended model from Lee and Carter (1992):
ln(mx,t) = b
1
x + b
2
xk
1
t + dxgt + x,t (2.6)
where the newly included parameter dx denotes the real GDP per capita in loga-
rithm. They emphasised that the proposed model can generate more interpretable
scenarios about future longevity based on the forecast of future economic growth.
What is more, French and O’Hare (2014) found the correlations between the latent
factor structure within mortality data and a selection of health and economic
factors in their study. The inclusion of exogenous determinants of health factors
such as gross domestic product (GDP), health expenditure and lifestyle-related
risk provide better forecasts in the countries under study, the United States, the
United Kingdom, Japan, Finland and the Netherlands.
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More recently, Cairns et al. (2016) introduced a flexible multi-population, gravity-
type mortality model for older Danish Males. The population was divided into
ten sub-groups7 using a new aﬄuence index that combines wealth and income
reported on the Statistics Denmark national register database. The model provides
reasonable forecasts of mortality rates that preserve the sub-group rankings at all
ages.
In the very recent study conducted by Boonen and Li (2017), the inclusion of the
economic growth (represented by GDP per capita) signified to provide a better
in-sample fit and out-of-sample forecast performance for each group of countries
observed. Their multi-population model8, generates lower (higher) forecasted life
expectancy period for countries with high (low) GDP as compared to another
mortality model under study.
Concurrently, various studies were conducted to investigate the effect of macroeco-
nomic fluctuations on mortality in different socio-economic groups for various EU
countries such as the United Kingdom, Germany, the Netherlands, Spain, Greece,
Finland, Iceland, Denmark or Slovakia (Rolden et al., 2014; Granados and Ro-
driguez, 2015; Regidor et al., 2016; Cairns et al., 2016; Rosicova et al., 2016).
However, only a few authors proposed a new mortality model that incorporates
the identified exogenous economic factors; see for example (French and O’Hare,
2014; Niu and Melenberg, 2014; Boonen and Li, 2017).
In the next section, this study follows the idea presented by Niu and Melenberg
(2014) and examines the relationship between GDP and mortality rates for those
nine most populous Eurozone countries.
7For i subgroup they proposed the following formula,
log(mi,t,x) = β
(i)
0 (x) + k
(i)
1 (t) + (x− x¯)k(i)2 (t).
8The general model considered by Boonen and Li (2017) is given by
logmi,x,t = ai,x +
J∑
j=1
Bj,xKj,t +
L∑
l=1
γl,xgl,t + bi,xki,t + i,x,t,
i,x,t
i.i.d∼ N(0, σ2i,x),
where ai,x,bi,x, ki,t are the population-specific parameters,Kj,t is the j-th common latent mor-
tality trend, gl,t is the l-th principal component of GDP for the I populations, and Bj,x and γl,x
are their respective age-specific loadings.
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2.3 Mortality and GDP
This section describes the dataset used in this study and thereafter, observing the
trends in mortality index in respect to the macroeconomic factor (GDP) fluctua-
tions. Therefore, this study establishes that there is significant correlation between
mortality rate and economic growth.
2.3.1 Data from Selected Eurozone Countries
The mortality data is obtained from the Human Mortality Database (HMD)9 for
years 1960–201210. In line with the discussed literature, we estimate the mortality
experience only for the nine most populous Eurozone countries namely Austria,
Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal and Spain.
The estimations are based on the three selected mortality models, namely Lee and
Carter (1992) (LC), O’Hare and Li (2012) (OL), and Niu and Melenberg (2014)
(LC-GDP). Data for male, female and unisex11 have been analysed separately as
they portray different patterns of mortality.
As for the GDP data, our analysis is based on the yearly GDP per capita (con-
stant LCU)12 performance for these countries over the period of 1960–201213. All
data were downloaded from the World Bank website14. The countries were then
categorised into two groups based on the GDP trends that they experienced. As
depicted in Figure 2.2, similar trends were observed among the members of the
two groups of countries; Group A: Austria, Belgium, Germany, France and the
Netherlands; and Group B: Spain, Greece, Italy and Portugal.
The GDP performance for Austria, Belgium, Germany, France and the Nether-
lands (see Figure 2.2) show a promising growth over the considerable period. The
9The Human Mortality Database, which was furnished by the University of California, Berke-
ley (USA), and Max Planck Institute for Demographic Research (Germany), provides a detailed
mortality and population data accessible online at www.mortality.org or www.humanmortality.de
(2017).
10Except Greece, where data is available from 1981
11In other words, it is suitable for both sexes. In this study, the calculations are based on the
total number of deaths and exposure to risk.
12GDP is the sum of gross value added by all resident producers in the economy plus any
product taxes and minus any subsidies not included in the value of the products. It is calculated
without making deductions for depreciation of fabricated assets or for depletion and degradation
of natural resources. All data are in constant local currency.
13Except Germany, where data is available from 1970.
14http://data.worldbank.org/
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momentum of GDP growth keeps on improving, and significant growth can be
seen clearly upon the Euro (e) adoption in 1999.
(a) Log of GDP for Austria, Belgium,
France, Germany and Netherlands.
(b) Log of GDP for Greece, Italy, Por-
tugal and Spain.
Figure 2.2: Logarithm of GDP for Austria, Belgium, France, Germany,
Greece, Italy, Netherlands, Portugal and Spain. Data from 1960 till 2012 (ex-
cept Germany, 1970–2012).
Meanwhile, the GDP performance for Spain, Greece, Italy and Portugal (see Fig-
ure 2.2) also show an increasing trend over a considerable period. Despite having
a gradual growth over the period, the performance of these four countries is re-
mained to be the same upon the adoption of Euro (e) in 1999. A study conducted
by C¸iftc¸iog˘lu and Betyak (2014) on the crisis countries revealed that the monetary
union of the Eurozone did not automatically ensure a higher rate of economic
growth among its members. They further commented that the dynamics of eco-
nomic growth were ultimately driven by macroeconomics. This remark seems to
agree with the earlier findings of Drake and Mills (2010) and Giannone et al.
(2011) that the adoption of the Euro (e) did not bring significant jump in eco-
nomic growth to all Eurozone countries. However, besides keeping the same pace of
economic growth, these crisis countries have been outperformed remarkably since
joining the Eurozone. Following the union, they have been bailed out successfully
through the implementations of structural reforms like improving public finances,
reducing deficits, and cutting labour costs.
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2.3.2 Trends in Mortality Index and GDP Fluctuations
This study applies a similar technique to that of Niu and Melenberg (2014) in
examining the relationships between the LC mortality index k1t and the macroe-
conomic fluctuations. Like previous studies, we also agree that there is an inverse
relationship between the mortality index k1t and the positive economic growth. In
our study, based on the LC model parameters, we analyse the trend of the mor-
tality index k1t and the logarithm of GDP, separating the data for male, female
and unisex for each Eurozone country, accordingly.
This study first applies the Perron (1988) test for each dataset (males, females,
unisex) of the mortality and the logarithm of GDP performances for each country.
Results for male, female and unisex are similar (see Table 2.1). In all cases, there
is no evidence to reject the null hypothesis at the 1% level of significance level
except for the unisex result of Belgium.
Table 2.1: Results of Phillips - Perron (PP) Test
male female unisex ln(GDP)
Austria 3.996 2.888 3.039 -3.541∗∗
Belgium 3.469 0.700 -7.428 -3.676∗∗∗
France 3.459 0.916 1.986 -5.419∗∗∗
Germany 2.523 1.528 1.844 -1.834
Greece 1.039 0.542 0.751 3.237
Italy 6.087 1.272 3.073 -6.029∗∗∗
Netherlands 6.655 -0.256 2.593 -1.609
Portugal 2.956 2.072 2.479 -2.962∗∗
Spain 1.728 0.697 0.962 -3.425∗∗
Notes: ∗p < 0.10,∗∗ p < 0.05,∗∗∗ p < 0.01.
However, for the logarithm of GDP, this study may reject the null of non-stationarity15
for Austria, Portugal and Spain at the 5% significance level and Belgium, France
15Non-stationary data, as a rule, are unpredictable and cannot be modelled or forecasted. The
results obtained by using non-stationary time series may be spurious in that they may indicate
a relationship between two variables where one does not exist. In order to receive consistent,
reliable results, the non-stationary data needs to be transformed into stationary data.
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and Italy at the 1% significance level, respectively.To support this analysis, this
study then applies the Kwiatkowski et al. (1992) test (KPSS) on the same dataset.
As stated in Table 2.2, there is evidence to reject the null hypothesis that an observ-
able time series is stationary around a deterministic trend for all cases as all results
are greater than the significance level of 1%. Therefore, this study proceeds under
the assumption of the presence of a unit root in the time series. Subsequently,
this study performs the Johansen (1988) cointegration test. This is to analyse the
cointegration between the mortality index and the GDP performance.
Table 2.2: Results of Kwiatkowski - Phillips - Schmidt - Shin (KPSS) Test
male female unisex ln(GDP)
Austria 1.253 1.280 1.274 1.269
Belgium 1.264 1.298 1.289 1.264
France 1.282 1.302 1.295 1.258
Germany 0.962 0.997 0.990 1.048
Greece 0.971 0.982 0.977 0.897
Italy 1.255 1.296 1.283 1.260
Netherlands 1.199 1.266 1.281 1.256
Portugal 1.288 1.297 1.293 1.236
Spain 1.296 1.302 1.301 1.252
Table 2.3 presents the results of the Johansen’s test. The null of no cointegration
(r = 0) is only rejected for male, Germany at the 5% significance level, but the
null of one cointegration vector (r 6 1) is mostly rejected for male, female and
unisex for the majority of the countries at the 10% significance level. In other
words, Johansen cointegration tests indicate that the two series have a long-run
relationship. The analysis conducted above and as presented in Tables 2.1, 2.2
and 2.3, indicates a possible long run relationship between the macroeconomic
indicator (GDP) and the mortality rates in the countries under consideration, and
thus further analysis is conducted in the following sections.
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Table 2.3: Results of Johansen Cointegration Test
male female unisex
r 6 1 r = 0 r 6 1 r = 0 r 6 1 r = 0
Austria 19.39∗∗ 42.52 19.65∗∗ 38.85 19.45∗∗ 41.31
Belgium 26.99 34.97 20.35 29.91 24.59 30.83
France 22.37 33.80 20.17∗∗∗ 25.06 21.98 27.51
Germany 5.64∗ 12.69∗∗ 7.41∗ 19.11 7.47∗ 21.52
Greece 4.49∗ 18.21 4.87∗ 19.08 4.70∗ 18.88
Italy 17.23∗∗∗ 49.69 13.32∗ 43.69 15.30∗∗ 46.65
Netherlands 22.76 33.75 7.68∗ 23.61 16.08∗∗∗ 24.27
Portugal 9.96∗ 34.06 9.08∗ 40.34 0.47∗ 36.99
Spain 7.69∗ 40.00 7.83∗ 50.26 7.79∗ 45.05
Notes: ∗p < 0.10,∗∗ p < 0.05,∗∗∗ p < 0.01. Critical values for the null of r = 0 are: 7.52
for p < 0.10, 9.24 for p < 0.05, and 12.97 for p < 0.01. Critical values for null of r 6 1
are: 13.75 for p < 0.10, 15.67 for p < 0.05, and 20.2 for p < 0.01.
2.3.3 Correlations between Mortality Index and GDP Per-
formance
This study conducts correlation studies between changes of LC mortality index
k1t separated by male, female and unisex with GDP fluctuations through the ap-
plications of Pearson (1895)16, Kendall (1938)17 and Spearman (1904)18 tests. As
presented in Table 2.4, this study observes highly significant negative correlations
for all nine countries with respect to all panels, i.e., male, female and unisex. Ad-
ditionally, Spearman test provides the highest correlations for all panels of male,
female and unisex across all countries.
16Pearson’s correlation coefficient is the covariance of the two variables divided by the product
of their standard deviations. The form of the definition involves a “product moment”, that
is, the mean (the first moment about the origin) of the product of the mean-adjusted random
variables; hence the modifier product-moment in the name.
17It is a measure of rank correlation: the similarity of the orderings of the data when ranked
by each of the quantities.
18Spearman’s rank correlation coefficient is a nonparametric measure of statistical dependence
between two variables. It assesses how well the relationship between two variables can be de-
scribed using a monotonic function.
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As for the correlations between average mortality rates at individual ages with
GDP fluctuations, the majority of the countries except Greece are giving strong
correlations for all male, female and unisex. The peculiar results for Greece might
be due to the smaller range of data as compared to other Eurozone countries. For
male data (see Figure 2.3, blue curves), countries such as Portugal, Spain, Belgium
and France show weak correlation for ages ranging from 15–35 years old.
Strongest correlations are observed for almost all countries on 0-15 years old and
above 40 years old populations. For female data (see Figure 2.3, red curves),
countries such as Austria, Belgium, the Netherlands and France are less correlated
within the age range of 10–55 years old. The strongest correlations are observed
for ages 0–5 years old and above 55 years old. As for unisex (see Figure 2.3,
brown curves), producing quite similar results with the male data, they are highly
correlated from 0–15 years old and above 40 years old with the score of −0.95.
(a) Austria (b) Belgium
(c) France (d) Germany
(e) Greece (f) Italy
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(g) Netherlands (h) Portugal
(i) Spain
Figure 2.3: Correlation coefficients between the logarithm of GDP and mor-
tality rates for male (blue), female (red) and unisex (brown) for nine countries:
Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Portugal and
Spain. Data from 1960 to 2007 (except: Germany: 1970–2007, Greece: 1981–
2007).
As findings compare well with previous studies, this study finds that correlations
for older ages are extremely strong regardless of gender. Moreover, the correlations
fluctuations for ages above 50 is quite stable and firm. These results provide
some confidence that incorporating these important findings in the new model of
mortality is a worthwhile exercise.
This study includes the idea of incorporating the economic growth fluctuations
into the mortality model. However, differently from Niu and Melenberg (2014),
this study does not incorporate the observable factor of GDP directly into the
model. Based on the analysis of individual ages, this study includes the GDP
factor in relation to the age dependent, which reflects the impact of GDP on
the individual age. What is more, this study keeps all the good aspects of the
LC model extensions (like cohort effect introduced by Renshaw and Haberman
(2006), age-period by Cairns et al. (2006a), second period by Plat (2009), and
quadratic effect by O’Hare and Li (2012). For that reason, this study incorporates
the age dependent GDP related factor into the OL model. By doing so, this
study aims to provide another alternative perspective on understanding the various
models of mortality modelling. Based upon the findings of the analyses, this study
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formulates a new model incorporating the GDP factor. In the next section, this
study proposes the new model.
2.4 OL-GDP Model for Central Mortality Rates
Recently, a large number of new mortality models have been proposed to analyse
the performance of fitting the historical mortality rates and ability to project
more plausible mortality rates for the future. Many of these suffer from being over-
parametrised or have terms added in an ad-hoc manner which could not be justified
in terms of demographic significance. In addition, poor specification of a model
may attribute to incorrect cohort effects that will eventually lead to implausible
projections of the mortality rates. However, this study discovers that the presence
of a macroeconomic factor like GDP can implicitly represent a demographic change
on the demography (see Section 2.3 for details). This study extends the procedures
of O’Hare and Li model by constructing a new mortality model using a combination
of a toolkit function, Lifemetrics in R code and experts judgement. By following
the procedure, this study evaluates the performance of the new model against the
alternative models using robustness and statistical significance tests. This study
demonstrates the data from the nine most populous countries in the Eurozone.
Apparently, this procedure produces a relatively parsimonious model that ideally
fits the data well.
2.4.1 The proposed GDP-related model
To further assess the role of economic growth on mortality dynamics, this study
presents the new model fitting the GDP-related factor on the mortality index
using the OL model. Thus, that additional factor, cgx is a vector of correlation
coefficients between the logarithm of GDP per capita and mortality rates for ages
0–89.
ln(mx,t) = b
1
x + k
1
t + cgx(x¯− x)k2t + (x¯− x)+k3t + ([x¯− x]+)2k4t + γt−x + x,t (2.7)
The original model of O’Hare and Li (2012), is an extended version of the LC
model. By keeping all the good aspects of the LC model, the OL model provides
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new good features for better fitting and performance. This study observes simi-
lar factors of b1x, k
1
t as the original OL model while factor k
2
t allows varieties of
ages reflecting the historical observation of rates improvement for different ages,
including also the impact of economic fluctuations. Factors k3t and k
4
t capture the
effect of young age and the presence of non-linearity respectively.
This study conducts a comparative analysis between the proposed new model
against three other mortality models namely, LC, OL and the extended LC model
with GDP (hereafter referred to as the LC-GDP model) by Niu and Melenberg
(2014). This study indicates the new model as the extended version of the OL
model with GDP effect (hereafter referred to as the OL-GDP model).
2.4.2 Estimation and Quality of Fitting
Models with multi-parameters are commonly exposed to the identifiability prob-
lem. Like other multi-parametrised models, the OL-GDP is also experiencing the
same problem. Each parameter of the model tends to identify similar values of
the function of ln(mx,t). For more details see Plat (2009).

γ˜t−x = γt−x + ψ1 + (t− x)ψ2
k˜1t = k
1
t − ψ1 − (dx¯+ t)ψ2
k˜2t = k
2
t + dψ2
b˜1x = b
1
x + (1 + d)xψ2
(2.8)
where ψ1, ψ2 and d are constants.
Apparently, the identifiability problem can be resolved by setting the identifiability
constraints. Since the proposed model is a derivation of Plat (2009), O’Hare and
Li (2012), this study adopts their approach in setting up the constraints. At this
juncture, this study undertakes a similar approach to Cairns et al. (2009), by
applying some additional constraints to the model19. Thus,
19Cairns et al. (2006a) model has simpler structure, thus requiring fewer constraints.
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
∑c1
c=c0
γc = 0∑c1
c=c0
cγc = 0∑
t k
3
t = 0∑
t k
4
t = 0
(2.9)
where c0 and c1 are the earliest and latest year of birth to which a cohort effect is
fitted, where c = t − x. The last two constraints are only used to normalise the
estimates for factors: k3t and k
4
t .
In fitting the mortality rates, Lee and Carter (1992) used Singular Value Decom-
position (SVD) methodology. Then, Brouhns et al. (2002) improved the fitting of
the LC model by describing the number of deaths Dx,t as a Poisson distribution
with parameter (Ex,tmx,t). It is notable that the Brouhns et al. (2002) approach is
more plausible than SVD as it caters for heteroscedasticity of the mortality rates
for different ages. Indeed, their method has been adopted by many other authors
(Renshaw and Haberman, 2006; Cairns et al., 2009; Plat, 2009; O’Hare and Li,
2012; Seklecka et al., 2017a). For this reason, this study follows the approach from
the corresponding literatures. By adopting the Brouhns et al. (2002) approach,
this study assumes that:
Dx,t ∼ Poisson(Ex,tmx,t) (2.10)
The parameters are then estimated by maximising the log-likelihood function,
which is given by
L(ψ;D,E) =
∑
x,t
{Dx,t ln[Ex,tmx,t(ψ)]− Ex,tmx,t(ψ)− ln(Dx,t!)} (2.11)
This study uses the R-code from the software package “Lifemetrics”20 to calculate
the estimated values of the parameters. This package gives the opportunity to
make a good comparison between our proposed model and other existing models.
The procedure to fit the model leads to time series estimates of k1t , k
2
t , k
3
t , k
4
t ,
20“Lifemetrics” is an open source toolkit for measuring and managing longevity and mortality
risk, designed by J.P. Morgan; full methodology, R code and user guide are available on the
website of author: http://www.macs.hw.ac.uk/~andrewc/lifemetrics/. This package gives
the opportunity to make a good comparison between the proposed model and existing ones.
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and γt−x. After fitting the model, the function takes the fitted values of the time
series that suitably fit the ARIMA-processes. For this purpose, this study uses
the auto.arima function from the R package forecast, which is fully automatic
and returns best ARIMA model according to either Akaike Information Criterion
(AIC)21 or Bayesian Information Criterion (BIC)22 value.
(a) Austria (b) Belgium (c) France
(d) Germany (e) Greece (f) Italy
(g) Netherlands (h) Portugal (i) Spain
Figure 2.4: Plots for time dependent factor k1t for male (blue lines), female
(red lines) and unisex (brown lines) data for nine countries: Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain. The
fitting period is 1960–2007 (except Germany: 1970–2007 and Greece: 1981–
2007).
Figure 2.4 presents plots of the time dependent factor k1t for male (blue curve),
female (red curve) and unisex (brown curve) data for each of the Eurozone coun-
tries chosen in this study, Austria, Belgium, France, Germany, Greece, Italy, the
Netherlands, Portugal and Spain. Generally, as expected, the k1t factor shows a
21Where AIC= 2k−2 ln(L), L is the maximized value of the likelihood function for the model;
k is the number of estimated parameters in the model.
22BIC is defined in the following paragraphs of this section.
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decreasing and consistent trend for all nine countries over the study period. Con-
trasting this, the time dependent factor k2t is behaving uniquely for each country
with most of them appearing concave upwards (see Figure 2.5). Italy, Portugal
and Spain have negative values throughout the period whilst Greece is considered
to have a linear decreasing trend of k2t .
(a) Austria (b) Belgium (c) France
(d) Germany (e) Greece (f) Italy
(g) Netherlands (h) Portugal (i) Spain
Figure 2.5: Plots for time dependent factor k2t for male (blue lines), female
(red lines) and unisex (brown lines) data for nine countries: Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain. The
fitting period is 1960–2007 (except Germany: 1970–2007 and Greece: 1981–
2007).
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For time dependent factor of k3t (see Figure 2.6), a consistent trend is observed for
each male, female and unisex data (blue, red and brown curves, respectively) for
most countries. Moreover, the behaviours of k3t are fluctuating generally across
the period for most countries. What is more, this study observes a similar shape
of the k3t curves for three groups of countries, i.e., Austria and Belgium; Germany,
Greece and the Netherlands; France, Italy, Portugal and Spain.
(a) Austria (b) Belgium (c) France
(d) Germany (e) Greece (f) Italy
(g) Netherlands (h) Portugal (i) Spain
Figure 2.6: Plots for time dependent factor k3t for male (blue lines), female
(red lines) and unisex (brown lines) data for nine countries: Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain. The
fitting period is 1960–2007 (except Germany: 1970–2007 and Greece: 1981–
2007).
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Figure 2.7 presents the time dependent factor k4t for the nine Eurozone countries.
Surprisingly, all countries except Greece (as the earliest data available is from
1981) experience a similar trend with positive values during the earlier years and
declining values during years 1980–1990. This study also observes a similar shape
of curves for the same groups of countries as in the case of k3t (except results for
Germany).
(a) Austria (b) Belgium (c) France
(d) Germany (e) Greece (f) Italy
(g) Netherlands (h) Portugal (i) Spain
Figure 2.7: Plots for time dependent factor k4t for male (blue lines), female
(red lines) and unisex (brown lines) data for nine countries: Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain. The
fitting period is 1960–2007 (except Germany: 1970–2007 and Greece: 1981–
2007).
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This study then conducts the goodness of fitting by applying the popular measures
such as Mean Absolute Percent Error (MAPE), Mean Absolute Deviation (MAD)
and Bayesian Information Criterion (BIC). Measures for MAPE and MAD are
defined as below:
MAPE =
1
NM
∑
x,t
‖mˆx,t −mx,t‖
mx,t
(2.12)
and
MAD =
∑
x,t
‖mˆx,t −mx,t‖
NM
(2.13)
where mx,t and mˆx,t are the actual values and estimated values of mortality, M
(M = 90) is the age dimension and N (N = 48) is the time dimension. While the
measurement of BIC is as defined by Cairns et al. (2006b):
BIC = L(ψ)− 1
2
kln(p) (2.14)
where L(ψ) is the log-likelihood of the estimated parameter ψ, p is the number of
observations, and k is the number of parameters being estimated.
Table 2.5 presents the fitting results for male data measured by MAPE, BIC and
MAD for the nine Eurozone countries based on the four models: LC, LC–GDP,
OL and OL–GDP.
The OL-GDP model provides the best quality fittings of male data for most coun-
tries. For instance, in MAPE, the most significant improvement is observable
for Italy (32.7%, 28.3% and 14.7% regarding LC, OL and LC-GDP model, re-
spectively), Portugal (17.7%, 13.0% and 5.9% for LC, OL and LC-GDP model,
accordingly), Germany (18.6%, 7.5% and 8.9% regarding LC, OL and LC-GDP
model, respectively) and France (18.9%, 2.8%, and 3.7% for LC, OL and LC-GDP
model, accordingly). While, for Austria, Belgium and the Netherlands, MAPE
results for OL-GDP model are slightly worse in comparison to LC-GDP (which
has the smallest error).
In terms of MAD, replicating the MAPE results, the best improvement is notice-
able for Italy (45.5%, 17.2%, and 32.0% in comparison to LC, OL and LC-GDP
model, respectively). What is more, apart from the results for the Netherlands,
Portugal and Spain, OL-GDP gives smaller MAD error.
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Meanwhile, the best BIC outcomes are recorded for both models of OL and OL-
GDP, with Ol-GDP dominating most countries. While for Portugal, LC-GDP is
the best.
However, for female data, the results recorded are less positive. As presented
in Table 2.6, for both MAPE and MAD measures, most countries are best fitted
through the LC-GDP model, except for Greece and the Netherlands. However, the
results recorded for BIC vary. Austria, Belgium and the Netherlands are best fitted
by the LC model, Portugal and Spain fitted LC-GDP best and France, Germany
and Italy are best fitted by the OL-GDP model whilst Greece is best fitted by the
OL model. Even the results recorded by the OL-GDP model are not favourable,
the variances of its improvement on MAPE are relatively small compared to the
LC-GDP model. However, huge improvement is observed on MAD for the LC-
GDP model. Contrarily, BIC results provide major improvement of the OL-GDP
model compared to the LC model (except for Austria and Belgium).
Table 2.7 presents the results of MAPE, MAD and BIC for unisex data. Basically,
the outcomes from the three measures of unisex data are reflecting the outcomes
of the male data. In terms of MAPE and MAD results, the best outcomes are
recorded by both of the GDP-related models, LC-GDP and OL-GDP. Nonethe-
less, OL-GDP dominates the best quality fittings of unisex data for most of the
countries.
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Table 2.5: Quality Fitting Results of MAPE, MAD and BIC for Male
Proposed Model
(LC) (OL) (LC-GDP) (OL-GDP)
Panel A: Mean Absolute Percent Error (MAPE)
Austria 9.98% 9.66% 9.07% 9.55%
Belgium 8.64% 8.41% 7.99% 8.19%
France 6.27% 5.22% 5.28% 5.19%
Germany∗ 5.28% 4.64% 4.71% 4.29%
Greece∗∗ 9.69% 9.45% 9.69% 9.35%
Italy 8.07% 7.58% 6.37% 5.43%
Netherlands 8.23% 7.58% 7.03% 7.19%
Portugal 10.04% 9.50% 8.78% 8.26%
Spain 7.45% 7.33% 7.20% 6.78%
Panel B: Mean Absolute Deviation (MAD)
Austria 0.001357 0.001156 0.001191 0.001137
Belgium 0.001236 0.000929 0.001047 0.000882
France 0.000803 0.000690 0.000750 0.000682
Germany∗ 0.000789 0.000668 0.000719 0.000650
Greece∗∗ 0.000799 0.000781 0.000799 0.000702
Italy 0.001032 0.000680 0.000828 0.000563
Netherlands 0.001114 0.000584 0.000958 0.000595
Portugal 0.001442 0.001333 0.001257 0.001288
Spain 0.000875 0.000855 0.000767 0.000769
Panel C: Bayesian Information Criterion (BIC)
Austria -20482 -19498 -19819 -19696
Belgium -21443 -19756 -20354 -19797
France -36330 -28844 -32388 -28793
Germany∗ -29172 -23281 -27829 -22225
Greece∗∗ -11205 -10861 -11551 -10962
Italy -43164 -34287 -35274 -27852
Netherlands -22028 -19899 -20447 -19861
Portugal -23873 -23731 -22520 -22766
Spain -34115 -29846 -32797 -27243
Notes:∗ based on the data from 1970 to 2007, ∗∗ based on the data from 1981 to 2007.
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Table 2.6: Quality Fitting Results of MAPE, MAD and BIC for Female
Proposed Model
(LC) (OL) (LC-GDP) (OL-GDP)
Panel A: Mean Absolute Percent Error (MAPE)
Austria 14.30% 14.51% 14.19% 14.44%
Belgium 10.61% 10.84% 10.58% 10.80%
France 6.10% 6.01% 5.38% 5.70%
Germany∗ 5.06% 5.36% 4.95% 5.11%
Greece∗∗ 15.77% 14.34% 15.78% 14.50%
Italy 7.01% 6.93% 6.11% 6.55%
Netherlands 8.52% 9.09% 8.52% 8.66%
Portugal 9.90% 11.37% 9.43% 10.82%
Spain 7.71% 8.61% 7.10% 8.18%
Panel B: Mean Absolute Deviation (MAD)
Austria 0.000755 0.000803 0.000729 0.000801
Belgium 0.000622 0.000751 0.000618 0.000764
France 0.000438 0.000510 0.000383 0.000514
Germany∗ 0.000367 0.000471 0.000365 0.000483
Greece∗∗ 0.000849 0.000681 0.000849 0.000631
Italy 0.000567 0.000567 0.000448 0.000531
Netherlands 0.000456 0.000610 0.000456 0.000606
Portugal 0.000955 0.000931 0.000806 0.000907
Spain 0.000621 0.000766 0.000463 0.000745
Panel C: Bayesian Information Criterion (BIC)
Austria -18165 -18331 -18424 -18483
Belgium -18652 -18731 -18999 -18770
France -27149 -25310 -25987 -24951
Germany∗ -24863 -21823 -24976 -21153
Greece∗∗ -10944 -10188 -11291 -10289
Italy -29027 -26674 -26998 -25835
Netherlands -18320 -18943 -18690 -18876
Portugal -20559 -21024 -19878 -20919
Spain -26140 -26073 -24407 -25310
Notes:∗ based on the data from 1970 to 2007, ∗∗ based on the data from 1981 to 2007.
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Table 2.7: Quality Fitting Results of MAPE, MAD and BIC for Unisex
Proposed Model
(LC) (OL) (LC-GDP) (OL-GDP)
Panel A: Mean Absolute Percent Error (MAPE)
Austria 8.09% 7.99% 7.42% 7.97%
Belgium 6.72% 6.65% 6.46% 6.51%
France 5.62% 4.73% 4.84% 4.51%
Germany∗ 4.68% 4.22% 4.49% 3.88%
Greece∗∗ 8.06% 7.66% 8.06% 7.53%
Italy 6.78% 6.43% 5.55% 4.94%
Netherlands 5.67% 6.06% 5.32% 5.76%
Portugal 8.32% 8.76% 7.45% 7.55%
Spain 6.55% 7.00% 6.20% 6.47%
Panel B: Mean Absolute Deviation (MAD)
Austria 0.000822 0.000757 0.000745 0.000751
Belgium 0.000667 0.000618 0.000625 0.000601
France 0.000511 0.000483 0.000492 0.000472
Germany∗ 0.000528 0.000469 0.000521 0.000461
Greece∗∗ 0.000694 0.000590 0.000694 0.000587
Italy 0.000649 0.000548 0.000556 0.000456
Netherlands 0.000700 0.000454 0.000688 0.000432
Portugal 0.000996 0.000959 0.000822 0.000891
Spain 0.000653 0.000759 0.000505 0.000707
Panel C: Bayesian Information Criterion (BIC)
Austria -22450 -21367 -21793 -21458
Belgium -22382 -20977 -21998 -21037
France -41057 -32222 -37648 -31335
Germany∗ -39747 -28126 -38958 -26029
Greece∗∗ -12523 -11622 -12870 -11698
Italy -47870 -37899 -40406 -32044
Netherlands -22293 -21296 -22075 -21207
Portugal -26846 -27212 -24845 -26063
Spain -39148 -35698 -36469 -32325
Notes:∗ based on the data from 1970 to 2007, ∗∗ based on the data from 1981 to 2007.
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Generally, the proposed modification of the OL model (OL-GDP) gives better
results for most countries in comparison to other models. As presented in Table 2.5,
the proposed model (OL-GDP) performed well for most of the countries for male
data. For MAPE, six out of nine countries are best fitted by the OL-GDP model.
Likewise, for MAD, six out of nine countries are best fitted by the proposed model,
OL-GDP, and for BIC, five out of nine countries are best fitted by the OL-GDP.
On the other hand, for female data (see Table 2.6), LC-GDP dominates to best fit
most countries for MAPE and MAD measures. Contrasting this, for BIC measure,
OL-GDP and LC models outperform other models by fitting most of the countries.
France, Germany and Italy fit OL-GDP best whilst Austria, Belgium and the
Netherlands fit LC model well. On another hand, LC-GDP fits Portugal and
Spain better and OL fits Greece well.
It is interesting to note that although the best fitting of female data does not
promote the new proposed model, OL-GDP, the results still stand undoubtedly,
supporting the basis that the economic factor does give a significant impact on
the mortality trends. Factually, the next GDP incorporated factor of mortality
model, i.e., LC-GDP provides the best fitting of MAPE and MAD for all female
data in the selected Eurozone countries. Thus, these findings contribute to existing
literature such as Bhargava et al. (2001), Hanewald (2011), French and O’Hare
(2014), Niu and Melenberg (2014) and Khemka and Roberts (2015) in promoting
the significant impact of economic growth on mortality.
For unisex, as presented in Table 2.7, the proposed modification of the OL model
(OL-GDP) gives better results for most countries in comparison to the other mod-
els. The OL-GDP model dominates for most of the countries. For MAPE, LC-
GDP outperforms the OL-GDP for one country, but for MAD, six out of nine
countries are best fitted by the proposed model, OL-GDP, and for BIC, five out
of nine countries are best fitted by the OL-GDP.
The OL-GDP model gives better results for all MAPE, MAD and BIC measures,
for both male and unisex for France, Germany and Italy. However, for female
data, LC-GDP provides better results for MAPE and MAD. For male, if one only
considers the MAPE measure, Greece, Portugal and Spain are also on the list of
better fitting. MAD results are fitted best for almost all countries except for the
Netherlands, Portugal and Spain. For BIC measure, better fittings are observed
for France, Germany, Italy, the Netherlands and Spain. For unisex, MAPE fits
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best for Austria, France, Germany, Greece and Italy. Whilst MAD fits Belgium,
France, Germany, Greece and Italy well, and BIC works best for France, Germany,
Italy, the Netherlands and Spain. For better understanding, this study maps the
summary of quality fittings for all countries in Figure 2.8.
As presented in Figure 2.8, France, Germany and Italy provide the best fittings
to the new proposed model, OL-GDP for each MAPE, MAD and BIC results of
male, female and unisex. This might not be surprising as these three countries
are the most populous among the nine. As reported by Chen et al. (2017), the
size of a population has a significant effect on the uncertainty about the estimated
parameters and mortality projections. In their study, they found that there exists
a bias in the estimated covariance matrix of the random walk fitted to the period
effects when the size of the underlying population is small. As a consequence,
prediction intervals are rather wide for small populations even when parameter
uncertainty is ignored.
This study first analyses the behaviour of France towards the sensitivity of its
mortality rates on logarithm GDP for each year of age for male, female and uni-
sex. The trend of correlations of average mortality and logarithm GDP (over
time) across ages, are quite similar for male, female and unisex. However, the
correlations of logarithm GDP and mortality rates are relatively lower during age
15–30 years old especially for males, followed by unisex and females. Apparently,
the mortality rates at middle ages (50 years old onwards) are highly correlated
with economic growth. This might be generally due to the impact of the economy
towards the wellbeing of the mid-age populations.
For Germany, similar trends of correlations were observed among male, female
and unisex. They are relatively correlated throughout the period with female
remaining the most negatively correlated as compared to unisex and male. In
comparison to France, Germany appears to be less correlated. Unlike France,
the age group between 30–40 years old of Germany tends to be less correlated as
compared to other ages, especially for male.
As for Italy, similar patterns were also observed among male, female and unisex for
its correlations between mortality rates and GDP trend. As presented in Figure
10, some odd trend for male was captured at young ages between 10–20 years
old. The trend of female is likely to be consistent throughout the ages with very
high negative correlations between the GDP and mortality trends. The age group
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(a) Male
(b) Female
(c) Unisex
Figure 2.8: Intersections of France, Germany and Italy for the OL-GDP
model. (a) Male, (b) Female, (c) Unisex.
between 20–40 years old highlights a weaker correlation with male being least
correlated.
Overall, this study observes that the middle age group between 15–40 years old are
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less sensitive and unlikely correlated to the economic growth. It seems that at this
group of age, the decreasing trend in mortality rates does not relatively translate
to the increasing trend in GDP. It appears to us that at this age group, most of
the people are having an excellent condition of their health generally. Hence, the
economic status does not really give an impact on their health status.
2.4.3 Robustness Checks
Robustness testing is a very important feature of verifying a good model. In this
subsection, this study investigates the robustness of correlation between mortality
rates by age and GDP changes over time. Moreover, this study also analyses
the robustness of the results for the proposed model. Figure 2.9 plots separate
Pearson’s correlation coefficient for male, female and unisex (blue, red and brown
curves accordingly) data of the nine countries for two periods: 1960–2007 (solid
lines) and 1960–1997 (dashed lines) with appropriate modifications for Germany
(1970–2007, 1970–1997) and Greece (1981–2007, 1981–1997).
Generally, this study observes similar trends with significant negative correlations
for all countries and genders for both periods of time (38 and 48 years respectively,
except for Germany, 28 and 38 years and Greece, 17 and 27 years). However, if
this study looks into each country specifically, every country displays different
trends of correlations. Austria, Belgium and Greece have quite similar trends
for all genders in both periods. However, only Greece experiences a significant
positive correlation (up to 0.8) for male and unisex for ages 20–50. Portugal and
Spain experience a positive correlation for male between 0.3 and 0.4 during ages
15–30. For the most part, the fluctuations of correlations can be seen clearly for
ages 20–40 for all countries. Furthermore, this study found that a shorter period
of observations results in lower correlations. This can be clearly observed for all
countries except Greece. Apparently, the effect of the GDP on mortality rates is
more meaningful in the longer windows as opposed to shorter windows.
It is also interesting to note that regardless of the number of observations fitted
during the process, the general shape of the correlations remains the same. This
indicates that an age specific GDP-related factor is not very sensitive to the range
of data used during the parameter fitting process.
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(a) cgx for Austria (b) cgx for Belgium
(c) cgx for France (d) cgx for Germany
(e) cgx for Greece (f) cgx for Italy
(g) cgx for Netherlands (h) cgx for Portugal
(i) cgx for Spain
Figure 2.9: Correlation Coefficients between GDP and Mortality Rates for
Male (blue), Female (red) and Unisex (brown) Data from Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain for two
periods: 1960–2007 (solid lines) and 1960–1997 (dashed lines) with appropri-
ate modifications for Germany (1970–2007, 1970–1997) and Greece (1981–2007,
1981–1997).
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During the fitting process, this study uses a dataset over the period from 1960 to
2007 (with appropriate modifications for Germany and Greece), and for the age
range of 0–89. A few years of the dataset are left for comparison purposes. This
study reduces the fitting period from 1960–2007 to 1960–1997 in order to have
a longer comparison period for the forecasting results. MAPE results for shorter
periods of time are presented in Table 2.8.
Table 2.8: MAPE for each of Eurozone Country over Fitting Period 1960–1997
(except Germany and Greece where this study has 1970–1997 and 1981–1997,
respectively).
male female unisex
Austria 8.62% 12.48% 6.97%
Belgium 7.39% 9.92% 5.95%
France 5.05% 5.17% 4.37%
Germany 3.42% 3.91% 2.81%
Greece 8.39% 10.92% 6.54%
Italy 5.10% 5.50% 4.48%
Netherlands 6.52% 7.59% 5.19%
Portugal 7.42% 9.70% 6.80%
Spain 6.49% 7.39% 6.13%
2.5 Forecasting Life Expectancy and Longevity
Risk
This study uses the OL-GDP model to forecast future mortality rates for each
Eurozone country by fitting their historical mortality rates, respectively. The
forecasting caters for each of male, female and unisex ages 0–89 over the period
of 2008–2027. Specifically, this study groups the data into two sections, in-sample
and out-of-sample data for MAPE. The in-sample data used for Austria, Belgium,
France, Italy, the Netherlands, Portugal and Spain are from 1960 to 2007, whilst
for Germany and Greece are 1970–2007 and 1981–2007, respectively. This study
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uses the remaining of 2008–2012 data to test the forecasting performance (out-of-
sample) by using MAPE.
Time-dependent factors of the OL-GDP model are forecasted using the Autoregres-
sive Moving Average (ARIMA) and Exponential Smoothing (ES) for the period
from 2008–2027. For the ARIMA approach, this study uses the forecast.Arima
function from R package forecast. As the data set used differs for each country
and each gender, parameters estimates for the ARIMA (p, d, q)23 also need to be
tailored to each country and gender respectively. For instance, Table 2.9 presents
the parameters (p, d, q) used for each ARIMA model in each Eurozone country of
k1t factor for male, female and unisex data.
Table 2.9: ARIMA Model Parameters (p, d, q) for the k1t Factor for each of
Eurozone Country.
male female unisex
Austria (0, 2, 1) (0, 2, 1) (0, 2, 1)
Belgium (0, 2, 1) (0, 2, 2) (0, 2, 1)
France (2, 2, 1) (0, 1, 1) (2, 2, 1)
Germany (1, 2, 0) (1, 2, 0) (1, 2, 0)
Greece (0, 1, 1) (0, 1, 1) (0, 1, 1)
Italy (0, 2, 2) (0, 2, 2) (2, 2, 1)
Netherlands (1, 2, 1) (1, 2, 1) (2, 2, 0)
Portugal (0, 1, 1) (1, 2, 1) (1, 1, 0)
Spain (1, 2, 1) (0, 2, 2) (1, 2, 1)
For comparison purposes, this study estimates the same dataset using the ES
technique24 (for more details, see Hyndman and Booth (2008)) through the ets
function from the R package forecast. Additionally, to validate the ability of the
model in forecasting better results, this study extends the forecast on to other
models under study, LC, OL and LC-GDP.
23Parameters p, d, and q are non-negative integers, p is the order of the autoregressive model,
d is the degree of differencing, and q is the order of the moving-average model.
24Exponential Smoothing assigns exponentially decreasing weights as the observation get older.
In other words, recent observations are given relatively more weight in forecasting than the older
observations.
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As mentioned earlier, this study adopts the Mean Absolute Percentage Error
(MAPE) to study the performance of in-sample fitting and out-of-sample fore-
casting. For some reason, MAPE performs better than MSE as the mortality rate
varies significantly over different ages (Luo et al. (2016)). MSE will be influenced
solely by the larger mortality rate as varies drastically across age groups. Con-
trary, MAPE uses the percentage error that can better assess the in-sample fitting
and out-of-sample forecasting.
Table 2.10 illustrates the 5-year out-of-sample test for MAPE of the LC, OL,
LC-GDP and OL-GDP models for the period 2008–2012, using ARIMA and ES
estimation (Panel A and B, respectively). Overall, the proposed model, OL-GDP
gives better results in comparison to the LC, OL and LC-GDP models for all
countries and genders under study. Particularly, sizes of the improvement depend
on the respective country, gender and methodology. For example, for male’s re-
sults, an improvement of 42% is observed for Italy under ARIMA, in comparison
to the next best model, LC-GDP (58% against LC-GDP for ES). Similar perfor-
mance is observed for unisex data on Italy (41%, 46% against the next best model,
LC for ARIMA and ES, respectively). While, for female data, France scored the
highest rates of improvement, 14% for ARIMA and 17% for ES against the next
best model, LC-GDP. On average, ES performs better than ARIMA by providing
higher improvement rates against the next best model, LC-GDP for both male
and female, and OL for unisex. It is interesting to note that, for countries and
genders that promoting other models, our proposed model, OL-GDP stands to be
the next best model of choice compared to others (Male: Austria and Spain for
both ARIMA and ES, Female: Spain for ARIMA only, and Unisex: Austria and
Spain for both ARIMA and ES and Portugal for ARIMA only). Only for female
Austria (both ARIMA and ES) and unisex Portugal (ES) we ranked third.
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In view of a shorter period of forecasting (5 years) previously, this study considers
a longer forecasting period as an additional robustness check. This study uses the
38-year dataset (from 1960 to 1997)25 to calculate factors from the models, for
having a longer forecasting period of 15 years (1998–2012).
Table 2.11: Out-of-sample Test Results for MAPE (over the period 1998–
2012).
male female unisex
LC OL-GDP LC OL-GDP LC OL-GDP
Panel A: ARIMA
Austria 19.60% 19.75% 25.99% 28.59% 16.10% 13.94%
Belgium 18.12% 16.75% 19.32% 15.55% 15.28% 12.89%
France 23.56% 12.23% 17.61% 10.79% 19.79% 8.34%
Germany 15.94% 11.31% 16.32% 14.67% 15.33% 15.28%
Greece 19.59% 17.75% 30.56% 40.61% 15.35% 12.17%
Italy 21.03% 12.14% 16.01% 15.81% 15.26% 10.79%
Netherlands 19.53% 16.20% 20.43% 18.88% 15.93% 14.01%
Portugal 42.08% 27.38% 21.28% 19.71% 31.49% 27.38%
Spain 34.83% 31.98% 18.95% 18.78% 24.41% 17.59%
Panel B: Exponential Smoothing
Austria 19.73% 22.83% 25.99% 26.31% 16.09% 15.90%
Belgium 18.18% 14.41% 19.01% 15.34% 14.57% 12.30%
France 20.53% 12.72% 17.30% 17.22% 17.88% 12.55%
Germany 14.47% 12.16% 10.40% 10.37% 12.39% 9.97%
Greece 19.57% 19.17% 32.65% 33.64% 15.39% 15.94%
Italy 20.97% 13.45% 16.10% 15.43% 15.25% 11.00%
Netherlands 19.47% 19.32% 26.30% 26.02% 16.13% 11.18%
Portugal 40.78% 33.43% 19.90% 19.27% 30.32% 29.17%
Spain 34.78% 22.62% 15.62% 14.47% 24.38% 17.77%
25Except for Germany and Greece for which data is available from 1970 and 1981, respectively.
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Table 2.11 illustrates the 15-year out-of-sample test for MAPE of the proposed
new model and the LC model over the period of 1998–2012, using ARIMA and ES
estimation (Panel A and B, respectively). As presented in the table, the forecasting
performance varies between countries, genders, and methods used. Undoubtedly,
the proposed model fits better than the LC Model for most countries and genders
except for Austria (male-female, ARIMA-ES) and Greece (female, ARIMA-ES
and unisex, ES). For this period, this study also observes a better improvement
of the LC model for forecasting results under the ARIMA approach (the most
significant is France, 48.1%, 38.7% and 57.9% for male, female and unisex data,
respectively). While for ES, better results are observed for males from Austria,
Belgium and Spain (15.7%, 20.8%, 35.0%, respectively), and for unisex data from
Germany and the Netherlands (19.5%, 30.7%, respectively).
In managing the uncertainty of forecasting, this study forecasts the mortality rates
based on intervals of 5 and 95%percentiles. These intervals are also applicable to
all kt estimations that are being projected from the proposed model. This study
presents the illustrations of the forecasting results of mortality rates based on
the proposed model in Figure 2.10. The mortality rates are fitted from 1960
to 2007 (except for Germany, 1970 and Greece, 1981) and forecasted from 2008
to 2027, demonstrating the forecasting results for Male age 40 for each Eurozone
country (see Figure 2.10). Except for Greece, all other countries display sensible
forecasting results with a decreasing trend of mortality rates. The forecast results
for Greece exhibit greater volatility might be due to the country’s debt crisis post
2009. The behaviour of kt is depending on its volatility (Niu and Melenberg, 2014).
As shown in Figure 2.10, the estimated Male kt is least volatile in Italy and Spain,
corresponding to the narrowest intervals of the forecasts that are represented by
the dashed lines. Meanwhile, the estimated Male kt is most volatile in Greece,
referring to the widest intervals of the forecast.
At the end of this section, this study presents estimation examples from the OL-
GDP model. Figure 2.10 illustrates the fitted mortality rates for male (blue curve),
female (red curve) and unisex (brown curve) at age 40, from 1960–2007 (except
Germany: 1970–2007 and Greece: 1981–2007) followed by forecasting results from
2008–2027 (using ARIMA process). Additionally, the HMD data is marked for
comparison purposes (data from 1960 to 2012, except Germany: 1970–2012, and
Greece: 1981–2012). In general, shapes of the fitted mortality curve vary between
countries and genders, however, this study observes a decreasing trend for all
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of countries. Similar patterns are observable for the predicted values. Only for
Greece, mortality curve for male is increasing. This peculiar trend may result from
the economic crisis that hit Greece the hardest in 2008. A study conducted by
Laliotis et al. (2016), exploring the causal effect of the trend of mortality rates due
to the financial crisis that hit Europe, in particular Greece in 2008, they found
that, the mortality rates for Greece continued to decline after the onset of the
crisis period, but at a slower pace than before the recession. This reduction in
decline is more evident for females than for males. The reasons for this might be
due to sharp increase of death from suicides, homicides, mental health problems,
nervous system diseases and digestive diseases. As such, most of the causes of
death mentioned are related closely to the post crisis effect. Moreover, these
causes of death are contributed largely by males rather than females, as men tend
to be the breadwinner for the families.
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(a) mt,x for Austria (b) mt,x for Belgium
(c) mt,x for France (d) mt,x for Germany
(e) mt,x for Greece (f) mt,x for Italy
(g) mt,x for Netherlands (h) mt,x for Portugal
(i) mt,x for Spain
Figure 2.10: Mortality Rates for 40 year old Males (blue), Females (red) and
Unisex (brown) Data from Austria, Belgium, France, Germany, Greece, Italy,
the Netherlands, Portugal and Spain. Fitted to the HMD data from 1960 to
2007 (except Germany: 1970–2007, and Greece: 1981–2007) and followed by
forecasting results 2008–2027 (solid lines). Markers show relevant data from
HMD.
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2.6 Conclusion
The recent study conducted by Niu and Melenberg (2014) provides motivation to
further explore the association between the trends in mortality and GDP growth.
Unlike Niu and Melenberg (2014) who based their investigation on the Lee and
Carter (1992) (LC) model, this study is based on the O’Hare and Li (2012) (OL)
model, as this model captures the non-linear profile of mortality at a young age as
well as providing a better fit for a range of countries worldwide. The former study
incorporated the presence of GDP growth directly in the LC model (LC-GDP)
for six OECD countries (the USA, Canada, the UK, the Netherlands, Australia
and Japan). Differently from Niu and Melenberg (2014), this study focuses on
selected Eurozone countires,(Austria, Belgium, France, Germany, Greece, Italy,
the Netherlands, Portugal and Spain) and proposes a new model, (OL-GDP) by
including the GDP-age dependent factor into the existing model of OL. This as-
sociation reflects the GDP impact on the respective age individually.
To summarize: First, this study investigates the correlations between the latent
mortality index of k1t and the growth of logarithmic GDP based on the LC model.
The observations provide strong negative correlations between average mortality
rates and GDP trend for all sexes across all ages. Moreover, correlations at older
age are much stronger for most Eurozone countries except Greece. Evidently,
through the quality of fitting measures of MAPE, MAD and BIC, the new model,
OL-GDP fits best most countries as compared to other mortality models (LC, OL
and LC-GDP). This study notes the impact of GDP is more significant especially
in the most populous countries as the best fittings of the OL-GDP model are
observed for France, Germany and Italy. For this reason, this model may also
appropriate to be extended to other developed country like US and also to other
developing countries like China and India since there are populous countries.
What is more, OL-GDP model also demonstrates better quality forecasts of mor-
tality rates through the applications of ARIMA process and Exponential Smooth-
ing techniques. Essentially, the MAPE measure of forecasting shows a significant
improvement in forecasting results for shorter (5 years) and longer (15 years) pe-
riods of times in comparison to the LC model which acts as the reference model.
The impact of economic growth on mortality dynamics has proved to be note-
worthy. Further investigation on this will certainly shed some light on mortality
studies. An in-depth study on this subject will absolutely give a clearer picture
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of this association in explaining the mortality trends more precisely. At the same
time, this will definitely improve the mortality forecasting accuracy.
Chapter 3
OL-GDP Model Impacts on
Insurance Pricing and Reserving
3.1 Introduction
Over the past decades, the world has experienced rapid improvements in life ex-
pectancies. Many industrialised countries witnessed a consistent rising of human
longevity at a promising and significant pace. The main reason driving this phe-
nomenon is said to be a reduction of death rates among the older people (Cox et al.,
2010; Denuit et al., 2007). Factors like socio-economic status, medical innovations,
nutrition habits and environmental conditions are believed to be the contributing
aspects of this occurrence (French and O’Hare, 2014; Gaille and Sherris, 2010;
Post and Hanewald, 2013). Whilst reflecting a positive milestone of society’s so-
cial standing and well-being, longevity has also posed challenges and threats for
some organisations.
The evolution of longevity trends is believed to provide a new curve on the standard
life expectancy table, underestimating the current one. This threat has drawn the
attention of organisations like pension funds, life and health insurers and also
individuals. In particular, holders of longevity risk need to be more mindful in
terms of funding, pricing and reserving their products sufficiently. Governments
need to be vigilant in funding the ageing people, insurers need to be attentive in
providing conducive and inclusive healthcare solutions, and individuals need to
be careful in planning their favourable post-retirement. Consequently, a suitable
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choice of mortality models and a reliable reference of forecasted mortality rates are
deemed crucial in mitigating the longevity risk. Therefore, an accurate forecast of
future mortality experiences should be done carefully and precisely.
Apparently, the relationship between economic growth and mortality improvement
has long been discussed and presented by many researchers since the beginning
of the 21st century (Regidor et al., 2016; Niu and Melenberg, 2014; French and
O’Hare, 2014; Hanewald, 2011; Granados, 2008; Preston, 2007; Brenner, 2005;
Bhargava et al., 2001). They have mainly focused on the effect of macroeconomic
fluctuations on mortality in different socio-economic groups of various countries.
However, only a small number of researchers extended this study into the es-
tablishment of a new mortality model, incorporating the effect of the economic
fluctuations or GDP (Boonen and Li, 2017; French and O’Hare, 2014; Niu and
Melenberg, 2014).
Earlier (in Subsection 2.4.1), this study had established a new mortality model
describing the GDP-age dependent factor and its connection to the mortality ex-
perience (please refer to Equation 2.7). Due to its relevance and reliability, this
model is well-suited and best-fitted for most of the selected Eurozone countries
under study. The Model also provides more plausible forecasts of mortality rates
over the 20-year projections for a significant number of Eurozone countries.
One of the main objectives of this study is to investigate the robustness of the
OL-GDP model. As presented earlier, the correlation coefficients between GDP
and mortality, cgx, is used in formulating the OL-GDP model. Thus, this model
may suffer from sampling error in estimating the parameter of cgx. However,
upon fitting the data, the OL-GDP model still outperform other mortality models
by providing the least error compared to other models. Hence, to address the
sampling error may not significantly improve the model.
Besides, this study examines the impact of the OL-GDP model on its ability to
forecast the mortality rates if the parameters involved in the model are modified.
Further analysis would also be conducted to study sensitivity of each parameter’s
variations against the model. Subsequently, the next focus of this study is to look
at the impact of the OL-GDP model from the financial perspective on insurance
and annuity products. Impact on pricing and reserving of the actuarial products
are demonstrated in the following section. The model allows for simple quantita-
tive measures of those parameters in connections to mortality forecasts. This is
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crucial in developing long-term mortality projections, which constitute an impor-
tant issue in life insurance and pensions. A reliable and robust model provides
an accurate forecast of mortality rates and an efficient pricing strategy that may
address the issues of under-estimation of longevity risk and under-pricing of the
financial products.
The rest of this chapter is organised as follows. Section 3.2 presents an analysis
of the impact of various factors involved in the OL-GDP model. Based on the
outcomes of Section 3.2, the sensitivity analyses are presented in Section 3.3. This
section presents the impact of changes of the parameters of the OL-GDP model
and other mortality models under study over insurance pricing for selected actu-
arial products. Section 3.4 presents the results of actuarial reserving for selected
actuarial products. Finally, Section 3.5 concludes the whole discussion of this
chapter.
3.2 Impact of Various Factors Involved in the
OL-GDP Model
Socio-economic factors such GDP, inflation, unemployment have clearly been ob-
served to have a causal effect on mortality experience. Major studies showed that
improvements in mortality are accompanied by GDP growth. These co-movements
have lasted for many years and are unlikely to be coincidental. Evidently, Boonen
and Li (2017) claimed that the long run correlations between mortality develop-
ments and economic growth have been empirically studied before. In this section,
the impact of various factors involved in the OL-GDP model is examined. Factors
like age range, correlation coefficients, cgx, age parameter and time dependent
factor k2t are being analysed.
3.2.1 Age Range
In the previous chapter, this study focused on the age range between 0–89 years
old. To further study the impact and the sensitivity of the age range against the
model, this study considers other age ranges such as 20–89 and 50–89 years old of
male populations only. This study uses the common measures like MAPE, MAD
and BIC to test the quality of fittings using the different sets of age ranges.
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Surprisingly, consistent results were recorded for each measure of MAPE, MAD
and BIC for each country. MAPE and BIC are fitting best for age range of 50–89
years old for all countries, while MAD measured well for age range of 0–89 years
old across all countries.
As reflected by the OL-GDP model, older ages generate more significant results of
the mortality rates. This is because, most of the time dependant factors become
insignificant at an old age. Contrarily, the GDP effect will be more significant
towards the time dependant factor of k2t at an old age. Tables 3.1, 3.2 and 3.3
display the results of quality fittings over the different ranges of age for all nine
Eurozone countries selected.
MAPE
Country/Age 0-89 20-89 50-89
Austria 9.55% 5.53% 3.02%
Belgium 8.19% 4.75% 2.36%
France 5.19% 3.13% 1.31%
Germany 4.29% 2.81% 1.15%
Greece 9.35% 5.08% 2.89%
Italy 5.34% 3.47% 1.24%
Netherlands 7.20% 4.12% 2.00%
Portugal 8.26% 5.17% 2.78%
Spain 6.78% 4.39% 1.99%
Table 3.1: MAPE results for different age ranges of Male populations
MAD
Country/Age 0-89 20-89 50-89
Austria 0.001137 0.001448 0.002133
Belgium 0.000882 0.001090 0.001592
France 0.000681 0.000794 0.001090
Germany 0.000652 0.000777 0.000914
Greece 0.000702 0.000889 0.001459
Italy 0.000527 0.000622 0.000946
Netherlands 0.000597 0.000748 0.001086
Portugal 0.001288 0.001488 0.002084
Spain 0.000769 0.000921 0.001558
Table 3.2: MAD results for different age ranges of Male populations
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BIC
Country/Age 0-89 20-89 50-89
Austria -19695 -16013 -10088
Belgium -19797 -16302 -10336
France -28794 -21759 -11977
Germany -22217 -17668 -9921
Greece -10961 -9163 -5856
Italy -27443 -21878 -12110
Netherlands -19863 -16170 -10300
Portugal -22768 -16937 -10302
Spain -27243 -21345 -11978
Table 3.3: BIC results for different age ranges of Male populations
3.2.2 Correlation Coefficients
As the model incorporates the effect of GDP on mortality, this study denotes
this factor as cgx, a correlation coefficient between GDP and mortality rates. In
the previous chapter, this study investigated the correlations between the average
mortality rates (at individual ages) with the GDP fluctuations. The results showed
that all countries across all panels of male, female and unisex generated highly
negative correlations. This is in line with the findings from previous studies on
the negative relationship between mortality experience and GDP performance.
Moreover, as almost all of the findings are well-compared with the previous studies,
it is important to note that correlations for older ages are extremely strong and
stable for all genders.
In this chapter, this study investigates the impact of correlations between mortality
experience and GDP performance for different time periods of Eurozone countries,
Austria, Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal and
Spain for male populations only. Results in Figure 3.1 present various time periods
of 23-year, 33-year, 43-year and 53-year period used for all countries under study,
except for Germany (13, 23, 33 and 43 years) and Greece (12, 22 and 32 years) of
time period respectively.
As reflected clearly by all nine countries, longer time periods produce stronger
correlations as compared to the shorter periods. This is because, longer periods
provide more data that makes the coefficients correlate more in the long run. In
general, strongest correlations were observed for all countries for the time pe-
riod 1960–2012, except Germany (1970–2012) and Greece (1981–2012). Moreover,
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highest correlations were recorded for young ages (0–15 years old) and medium
ages (of above 40 years old). Countries like Austria, Belgium, France, Germany
and the Netherlands show persistent correlations over the period of 1960–2012.
Italy, Portugal and Spain recorded similar trends of correlations with weak results
particularly at the range between 25 to 30 years old. Peculiar results for Greece
might be due to the shorter period of data availability. However, there is a strong
negative correlation at 60 years of age and over.
3.2.3 Age Parameter
As reflected in the OL-GDP model, the age parameter acts as a tool to limit the
age range of the population under study. In the previous chapter, this study used
the average age, x¯ as the age parameter. In this subsection, this study extends
the research to various numbers of age parameters of 20, 40 and 60 years old for
Male populations only. This study uses the common measures of MAPE, MAD
and BIC to test the quality fittings for various age parameters. In general, age
parameter of 20 years old produce better results as compared to 40 and 60 years
old.
The impact of age parameter varies for each country. The results can be cat-
egorised into two groups, the young age, 20 and the old age 60. For instance,
age parameter of 20 years old, suits Belgium, France, Greece, Italy, Portugal and
Spain best. Meanwhile, Germany, Austria and Netherlands suit the 60 years old
age parameter best. Tables 3.4–3.12 display the results of MAPE, MAD and BIC
for various age parameters for all the nine countries under study. Based on these
findings, the age parameter of 20 gives the best simulation for most countries as
it provides better interpretation of the GDP effect by eliminating the effect from
other time dependent factors of kts.
Austria
Test/Age 20 40 60 Average
MAPE 9.55% 9.56% 9.54% 9.55%
MAD 0.001143 0.001138 0.001133 0.001137
BIC -19644 -19685 -19731 -19696
Table 3.4: Fitting Results of Austria by Age Parameters, Males
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(a) Austria (b) Belgium
(c) France (d) Germany
(e) Greece (f) Italy
(g) Netherlands (h) Portugal
(i) Spain
Figure 3.1: Correlation Coefficients between the Logarithm of GDP and Mor-
tality Rates for Male Populations of nine countries: Austria, Belgium, France,
Germany, Greece, Italy, the Netherlands, Portugal and Spain.
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Belgium
Test/Age 20 40 60 Average
MAPE 8.16% 8.18% 8.21% 8.19%
MAD 0.000884 0.000883 0.000882 0.000882
BIC -19772 -19792 -19815 -19797
Table 3.5: Fitting Results of Belgium by Age Parameters, Males
France
Test/Age 20 40 60 Average
MAPE 5.13% 5.18% 5.23% 5.19%
MAD 0.000677 0.000680 0.000687 0.000682
BIC -28502 -28732 -29030 -28793
Table 3.6: Fitting Results of France by Age Parameters, Males
Germany
Test/Age 20 40 60 Average
MAPE 4.29% 4.29% 4.29% 4.29%
MAD 0.000656 0.000653 0.000650 0.000650
BIC -22255 -22224 -22195 -22225
Table 3.7: Fitting Results of Germany by Age Parameters, Males
Greece
Test/Age 20 40 60 Average
MAPE 9.23% 9.31% 9.68% 9.35%
MAD 0.000679 0.000695 0.000724 0.000702
BIC -10949 -10953 -11064 -10962
Table 3.8: Fitting Results of Greece by Age Parameters, Males
Italy
Test/Age 20 40 60 Average
MAPE 5.32% 5.33% 5.36% 5.43%
MAD 0.000515 0.000525 0.000539 0.000563
BIC -27325 -27415 -27555 -27852
Table 3.9: Fitting Results of Italy by Age Parameters, Males
Netherlands
Test/Age 20 40 60 Average
MAPE 7.21% 7.19% 7.20% 7.19%
MAD 0.000635 0.000602 0.000585 0.000595
BIC -19968 -19874 -19848 19861
Table 3.10: Fitting Results of Netherlands by Age Parameters, Males
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Portugal
Test/Age 20 40 60 Average
MAPE 8.27% 8.27% 8.26% 8.26%
MAD 0.001276 0.001285 0.001297 0.001288
BIC -22747 -22764 -22784 -22766
Table 3.11: Fitting Results of Portugal by Age Parameters, Males
Spain
Test/Age 20 40 60 Average
MAPE 6.78% 6.78% 6.79% 6.78%
MAD 0.000774 0.006769 0.000773 0.000769
BIC -27185 -27226 -27318 -27243
Table 3.12: Fitting Results of Spain by Age Parameters, Males
3.2.4 Estimation of k2t Factor
As discussed earlier in Subsection 3.2.1, the model includes the additional factor
of GDP. This additional factor acts as a vector of correlation coefficients between
the logarithm of GDP per capita and mortality rates for ages between 0–89 years
old. The impact of the GDP vector was tested against the age dimension and the
time-dependent factor of k2t . The k
2
t factor allows for variations of age that reflect
the historical observations of rates improvement for different selection of ages.
In this subsection, this study estimates the variations of k2t factor at 5% intervals.
The data used in this estimation is based on the period range of 1960–2012. The
variations of the k2t were tested on the 2000-2012 range of data for male populations
age 20 and 60 years old respectively. Figure 3.2 displays the central mortality
rates for male populations age 20 and 60 years old respectively for all the nine
countries. This study observed that variations of k2t do not have significant impact
on the mortality rates especially for younger ages. For older ages, like 60 years
of age, small changes of mortality rates were observed for some countries (Italy
and the Netherlands). Other countries’ mortality rates, remain unchanged. This
shows that, the impact of GDP does not really affect any particular age of the
populations, as it impacts the population as a whole for the specified time period
under observation.
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(a) Austria
(b) Belgium
(c) France
(d) Germany
(e) Greece
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(f) Italy
(g) Netherlands
(h) Portugal
(i) Spain
Figure 3.2: Central Mortality Rates for Male Populations (1960–2012) for
Different Values of k2t from 2000–2012, for Ages 20 and 60 years old respectively.
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3.2.5 Fitting and Forecasting of OL-GDP model
Besides the characteristics of factors used in the model formulation, the choice
of forecasting methodologies also influence the projection of the mortality rates.
Different forecasting tools tend to produce different projected rates. In this study,
it considers the simple Naive1, Arima2, the Exponential Smoothing (ES)3 and the
Cubic Smoothing Spline (CSS)4 as the methods used for forecasting. Naive method
is used as a benchmark against other sophisticated forecasting methods like Arima,
ES and CSS. ES approach is based on the weighted average of past observations,
with the older observation weights declining exponentially; meaning, the most re-
cent observations have higher weights (Hyndman and Booth, 2008). The Arima
technique uses a variation between seasonal and non-seasonal data which combines
unit root tests and returns the best model accroding to either Akaike Information
Criterion (AIC) or Bayesian Information Criterion (BIC) values. The CSS ap-
proach, uses the spline interpolation method, in which the interpolant used is a
special type of piecewise polynomial function. Again, in this subsection, the im-
pact of the forecasting methods was tested on the estimated data derived from the
OL-GDP model against the fitted data extracted from the HMD. The variations
were tested on the male populations aged 40 years old for all the nine countries.
The fitting period is 48 years (1960–2007), (except Germany and Greece, for which
it is 38 and 27 years respectively) and the forecasting period is 20 years (2008–
2027). To be consistent with the previous exercise, this study uses the R package
named “forecast” to estimate the future values of those factors involved in the
model. This “forecast” package is fully automated in searching over the best
model within the constraints provided.
1The Naive method is the simplest method of forecasting. The forecasting values are equiva-
lent to the last observed value.
2Autoregressive Integrated Moving Average (ARIMA) used to predict future points in the
series. The AR part involves the regression of its own lagged values. The MA part indicates
regression errors that occurred at various times in the past. The I (Integrated) indicates the
difference between their values and the previous ones. The combination of these features is to
make the model fit the data as well as possible.
3Exponential smoothing (ES) is a technique for smoothing time series data. Particularly, the
simple moving averages are weighted equally while the weights used are decreasing exponentially
over time.
4The smoothing spline is a method of fitting a smooth curve using a spline function. Spline
is better than polynomial as it produces less error during the interpolation process.
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Figure 3.3 presents the forecasting results of central mortality rates for all coun-
tries. In general, all three methods, Arima, ES and CSS, generated better fore-
casts of mortality rates compared to Naive for all countries except Greece. Due
to data limitations, Greece produced strange results for each method of forecast-
ing. For Greece, ES technique generated quite similar results as Naive. While
Arima and ES tend to forecast upward. Consistent forecasting results were gen-
erated by Arima, ES and CSS for Austria and Italy. The difference among these
three methods are relatively small. On another note, in general, both Arima and
ES methods produced similar forecasting results for all countries except for the
Netherlands and Greece. Overall, it is interesting to note that all methods (ex-
cept Naive) are producing downward forecasts of mortality trends for all countries
except Greece.
3.3 Actuarial Pricing Methodologies
Mortality models have been commonly used as bases for projecting mortality rates.
An accurate projection of mortality rates is deemed critical in planning for organ-
isation’s sustainability. Some important classes of liabilities lie in organisations
like life insurance and pensions as they are sensitive to the direction of future mor-
tality trends. They rely their pricing and funding strategies diligently on prudent
life tables. These life tables are based on assumptions that future death rates are
known with certainty.
Developments in longevity improvements over the last few decades have led to
uncertainty and ambiguity of future scenarios in planning and managing the mor-
tality and longevity risks. Life insurers, pension funds and annuity providers are
increasingly aware of their exposure to the risk of mortality changes and the need
for better models for risk management (Sherris and Wills, 2008). The evolution
of longevity risk has also modified the standard curve of life expectancies, un-
derestimating the future ones (Barrieu et al., 2012). Issues like insufficient funds
and inadequate protections are crucial in promoting a companys solvency. Life
insurers and pension fund providers are increasingly mindful of the longevity risk
and the needs for vigilant models of risk management. Actuarially, their mortality
models need to be integrated into financial models in pricing their insurances and
reserving their funds diligently.
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(a) Austria (b) Belgium
(c) France (d) Germany
(e) Greece (f) Italy
(g) Netherlands (h) Portugal
(i) Spain
Figure 3.3: Fitted mortality rates of HMD data for Austria, Belgium, France,
Germany, Greece, Italy, the Netherlands, Portugal and Spain from 1960–2007
(except Germany: 1970–2007 and Greece: 1981–2007) and followed by the fore-
casted mortality rates from 2008–2027 for various methods of forecasting.
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In the previous section, this study considered the impact of the GDP-age depen-
dent mortality model, OL-GDP given the variations on its parameters. Following
this, by reflecting the variations and range of modifiable factors involved in the
model, this study believes that these may have an impact on the actuarial present
value5 (APV) of life annuities and life insurances. Factors like choices of data
period and forecasting methods, also variations of correlation coefficients, interest
rates, age groups and age parameters will be observed in this section.
Mainly, life insurance products offer two types of services; income replacement for
premature death and long-term savings instruments. Different types of policies of-
fer different coverage options and choices of investment to policyholders. Policies
that offer the mortality coverage only are also known as term insurance. Mean-
while, those policies that combine the mortality coverage with a savings element
are known as whole life and endowment insurances. Pure endowment is a type of
insurance that offers a long-term savings only. Under this policy, the policyholder
will get the benefits at the end of the policy period if the insured is alive. If the
insured has died, there is nothing paid in the form of benefits. Policies that offer
combinations between mortality coverage with savings element are typically earn-
ing interest, which is returned to the policyholder through policy dividends, cash
values on termination of the policy or endowment sums on the policy maturity.
Besides the life insurance products, life insurers also sell annuity products. Annu-
ities are contractual financial products that are designed to accept and grow funds
from the annuitant. The period when an annuity is being funded and before pay
outs begin is referred to as the accumulation phase. Upon annuitisation, annui-
tants will receive a lump sum or periodic payments until their death. Once the
payments commence, the contract is in the annuitisation phase. At this point of
time, insurers undertake risks associated with the longevity of the annuitant.
For the most part, this study considers four basic actuarial products namely term
annuity, term insurance, endowment insurance and pure endowment insurance.
The details of these products are described below:
(a) Term annuity due n-year annuity due where payments of £1 is made at the
beginning of the year while an individual is alive for at most n years;
5Actuarial Present Value (APV) is the expected present value of a contingent cash flow
stream, i.e., a series of payments that may or may not be made. APVs are typically calculated
for the benefit-payment or series of payments associated with life insurance and life annuities.
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a¨x:n =
n−1∑
k=0
vkkpx, (3.1)
(b) Term insurance – n-year term life insurance where the death benefit payment
of £1 is payable if the insured dies within the policy term;
A1x:n =
n−1∑
k=0
vkkpxqx+k, (3.2)
(c) Pure endowment insurance – n-year pure endowment policy where the benefit
payment of £1 is payable at the end of the policy term if the insured is alive with
nothing payable in case of prior death (before maturity);
A 1x:n = v
n
npx, (3.3)
(d) Endowment insurance – n-year endowment policy where the benefit payment
of £1 is payable to the beneficiaries if the insured dies during the policy term or to
the insured on maturity of the policy if the insured survives the term, whichever
occurs first (it is a combination of the n-year term life insurance and n-year term
pure endowment insurance);
Ax:n =
n−1∑
k=0
vkkpxqx+k + v
n
npx, (3.4)
This study assumes deaths are uniformly distributed in the year of age, where the
relationship between the probability of death (as formulated in the APV formulae
above) and the central mortality rates (as generated by OL-GDP mortality model)
is as follows, see Bowers et al. (1997) for details:
qx =
mx
1 + 1
2
mx
, (3.5)
The annual effective interest rate,i, is assumed to be 3%, unless otherwise stated.
The discount function,v, is given by the formula:
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v =
1
1 + i
, (3.6)
In the following subsection, this study compares the APVs of the above mentioned
financial products against the various factors reflected within the mortality models.
This study bases its analysis on the Mean Percentage Error measure (MPE), which
is defined as follows:
MPE =
APV (estimated mortality rates)− APV (mortality rates)
APV (mortality rates)
, (3.7)
3.3.1 APV of Various Mortality Models
In this subsection, this study analyses the MPE results of four actuarial products
for nine Eurozone countries. The analysis is based on the actuarial present values
(APVs) for each actuarial product namely, annuity, term insurance, pure endow-
ment and endowment. This study considers a term period, n = 20 years and the
effective rate of interest, i = 3%. This study further compares the MPE results
of the new model, OL-GDP against three other mortality models, Lee and Carter
(LC), O’Hare and Li (OL), Niu and Melenberg (LC-GDP). The analysis is con-
ducted for male data only over the fitting period of 1960–2007 (except Germany
and Greece, for which the fitting period is 1970–2007 and 1981–2007 respectively).
Figure 3.4: Austria – Actuarial Present Values (APVs)
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Figure 3.4 presents the MPE results of the APV for a 20-year term insurance,
annuity, pure endowment insurance and endowment insurance of Austria. The
results display the MPEs of male population ages 20, 40 and 60 years old. Different
actuarial products produces different results of MPE. In most cases, APVs for
young ages of 20 years old give the smallest error for all products as compared to
a 60-year old male population of Austria. The new GDP-age dependent model,
OL-GDP calculates the APV better for Annuity and Endowment products, while
for Pure Endowment product, OL model performs slightly better than the new
model, OL-GDP. For Term product, most of the models perform moderately across
all ages.
Figure 3.5: Belgium – Actuarial Present Values (APVs)
For Belgium (please refer to Figure 3.5), the MPE results of the four actuarial
products can be categorised into two groups. For instance, annuity and pure
endowment products produce similar trends of the APVs.The APVs are over-
estimated at older ages of 60 years old, whilst for term and endowment products,
the APVs are under-estimated for 60 years old age. Overall, our model, OL-GDP
gives the smallest and most consistent range of errors of APVs for all four products.
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Figure 3.6: France - Actuarial Present Values (APVs)
As presented in Figure 3.6, in general, the new model, OL-GDP provides the small-
est and most consistent range of errors of APV calculations for all four products
across all ages of 20, 40 and 60 years old for France. Better APV calculations are
observed at the middle ages of 40 years old for all products. APVs are over- and
under-estimated at age 60 for annuity, pure endowment and endowment products.
For term insurance products, the over-estimations of APV are observed for young
ages of 20 years old.
Figure 3.7: Germany - Actuarial Present Values (APVs)
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For Germany, the calculations of APV display over- and under-estimations for
medium to old ages of all the four products (Figure 3.7). Similar trends are
observed for term and endowment products, and another similar trend for annu-
ity and pure endowment products. For term and endowment products, all four
mortality models, LC, OL, LC-GDP and OL-GDP under-estimate the APV cal-
culations for ages 40 and 60 years old. Meanwhile, the APVs for annuity and
pure endowment products are over-estimated for the same ages of 40 and 60 years
old. Overall, our model, OL-GDP performs better as compared to other models.
Similar trends were observed for two groups of products, term and endowment,
Figure 3.8: Greece - Actuarial Present Values (APVs)
and annuity and pure endowment for Greece (please refer to Figure 3.8). For term
and endowment, all APVs are under-estimated for all ages of 20, 40 and 60 years
old. Significant range of errors is observed for term product. Whilst for annuity
and pure endowment products, range of errors is more visible for 60 years old. At
the same time, very small errors are detected for young age of 20 years old.
Figure 3.9 presents the APVs for Italy. Replicating Greece’s results, similar trends
are observed for the same groups of products, term and endowment, and annuity
and pure endowment. In addition, under-estimations of APV are observed for term
and endowment products and over-estimations for annuity and pure endowment
products. The new model, OL-GDP seems to provide consistent calculations of
APV for all products across all ages.
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Figure 3.9: Italy - Actuarial Present Values (APVs)
Figure 3.10: Netherlands - Actuarial Present Values (APVs)
Results for the Netherlands are consistent for ages 20 and 40 years old for annuity,
pure endowment and endowment products (please refer to Figure 3.10). Opposite
trends are observed for age 60 years old of annuity and endowment products.
Under-estimations occur at the ages of 20 and 40 years old for all mortality models
of term and endowment products except for 40 years old of term insurance.
For Portugal (please refer to Figure 3.11), similar observations were noted like for
the majority of the countries discussed. Opposite characteristics were reported for
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Figure 3.11: Portugal - Actuarial Present Values (APVs)
two groups of products, term and endowment, and annuity and pure endowment.
Significant range of errors are spotted on the 20 years old male population across
the products.
Figure 3.12: Spain - Actuarial Present Values (APVs)
Results for Spain (please refer to Figure 3.12), are replicating closely the results
of Portugal. Significant range of errors are observed at the age of 20 years old.
Except for term product, there are also significant ranges of errors for 60 years old
of annuity, pure endowment and endowment products. As before, the new model,
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OL-GDP tends to produce consistent measures of APVs for all products across all
ages. The errors produced by OL-GDP are relatively small.
3.3.2 APV of Various Forecasting Methods
This subsection investigates the impact of the forecasting methods on the APVs of
four actuarial products namely Annuity, Term Insurance, Endowment Insurance
and Pure Endowment. As discussed in subsection 3.2.5, the choice of forecasting
methodologies also influences the projection of the mortality rates. Different fore-
casting tools tend to produce different projected rates. Under this observation, the
forecasting was done on the forecasted mortality rates in 2014. The forecasting
methods used are Naive, Arima, ES and CSS. The interest rate, i used is 3%. This
insurance and annuity products are issued to a male age of 30 years old, for the
term period of 20 years across all products.
As presented in Figure 3.13, term insurance product provides the biggest errors
for all forecasting methods across all countries. In addition, as reflected by all
forecasting methods, the term insurance product is over-estimated in most of the
countries except Germany, Italy, the Netherlands and Portugal. Among all meth-
ods, Naive produced the highest overestimated errors for all countries with the
highest over-estimation being recorded for Spain at 0.5%. ES performs excep-
tionally well in Austria, where the MPEs for all products are almost zero. Other
forecasting methods also performed well for Austria except for the Naive approach
of term insurance product. For Belgium, both methods of Arima and CS are per-
forming incredibly, where all products recorded almost zero results of the MPEs.
Except for the the Netherlands and Greece, Arima and ES methods generate
quite similar results of MPE for all products. CSS method produces the least
error against other forecasting methods across all products in Germany, Italy and
Spain. Under-estimations are significantly observed in Italy and Netherlands for
all methods except Naive. In Portugal, the underestimation is recorded under CSS
method for term insurance product.
In general, with the exclusion of term insurance product, all of the forecasting
methods perform exceptionally well for annuity, endowment insurance and pure
endowment insurance across all countries.
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(a) Austria (b) Belgium
(c) France (d) Germany
(e) Greece (f) Italy
(g) Netherlands (h) Portugal
(i) Spain
Figure 3.13: Mean Percentage Error of Actuarial Present Values (APVs) for
a 30-year term of Annuity, Term Insurance, Endowment Insurance and Pure
Endowment Insurance based on the OL-GDP model issued to Male Popula-
tions age 30 years old using Naive, Arima, ES and CSS Forecasting methods
forecasted in 2014 against the actual value of HMD in 2014.
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3.3.3 APV of Various Interest Rates
Small changes of interest rates result to significant impact over APV. Evidently,
there is an inverse relationship between the interest rates and the present values.
The gradients of the trends are depending on the age of the insured and also the
length of the policy period. To verify this statement, this study examines the
impact of the interest rates and policy tenure on endowment policy for a person
ages 20, 40 and 60 years old respectively.
As recorded in Figures 3.14–3.22, higher interest rates tend to lower the values of
the APV. The length of the policy also affects the values of the APV. In general,
there are insignificant changes of interest rates for 20 and 40 years old. However,
there is a significant gap on 60 years old trends.
Figure 3.14: Austria - APV of Various Interest Rates, 3-5%
Figure 3.15: Belgium - APV of Various Interest Rates, 3-5%
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Figure 3.16: France - APV of Various Interest Rates, 3-5%
Figure 3.17: Germany - APV of Various Interest Rates, 3-5%
Figure 3.18: Greece - APV of Various Interest Rates, 3-5%
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Figure 3.19: Italy - APV of Various Interest Rates, 3-5%
Figure 3.20: Netherlands - APV of Various Interest Rates, 3-5%
Figure 3.21: Portugal - APV of Various Interest Rates, 3-5%
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Figure 3.22: Spain - APV of Various Interest Rates, 3-5%
3.3.4 Annual Premium of Various Models
Appropriate choice of mortality tables is crucial in calculating the insurance pre-
miums accurately. In this subsection, this study tabulates the annual insurance
premiums of common life insurance products like Term, Endowment and Pure
Endowment for the insurance term of 20 years. This study examines the annual
insurance premium for entry ages of 30 and 60 years old for all the nine countries
of the Eurozone. This study compares the annual insurance premiums against the
four mortality models of LC, OL, LC-GDP and OL-GDP for better understanding
the impact of mortality rates on the annual insurance premiums. Generally, the
premiums are tailored to the respective country. Each country produces different
results of the insurance premiums from different models of mortality.
Tables 3.13–3.21 present the illustrations of the annual premiums for 20-year life
insurance products with £1,000 benefit payment, payable at the end of the year
of death/maturity to a person aged 30 and 60 years old respectively. Focusing
on the OL-GDP model only, this model priced the annual premiums of 20–year
term insurance issued to a person ages 30 are between £1.05–£2.26 across the
nine Eurozone countries. The lowest annual premium is recorded for Netherlands
whilst the highest annual premium is recorded for Portugal. Similar results were
recorded for a 20–year endowment issued to the individual aged 30. The annual
premiums range between £36.59–£37.17, with the Netherlands and Portugal en-
tailing the lowest and highest annual premiums respectively. Inverse results were
recorded for a 20–year pure endowment, where the lowest annual premium was
priced for Portugal (£34.90), whilst the highest annual premium was priced for
the Netherlands (£35.53).
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For insurances issued to an individual aged 60, the 20–year term insurance is priced
between £20.10–£24.41. Italy had at the lowest annual premium and Portugal
recorded the highest annual premium. For the 20–year endowment insurance, the
range of the annual premiums recorded by OL-GDP is between £44.94–£47.16.
Again, Italy revealed at the lowest annual premium and Portugal was priced at
the highest annual premium. For the 20–year pure endowment, the lowest annual
premium was recorded by Portugal with £22.75 and the highest annual premium
was recorded by France with £24.98.
Austria, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.52 1.51 1.49 1.50
30 Endowment 36.77 36.78 36.76 36.78
Pure Endowment 35.24 35.27 35.27 35.27
Term Insurance 21.74 22.51 21.84 22.58
60 Endowment 46.03 46.38 46.18 46.42
Pure Endowment 24.29 23.86 24.34 23.84
Table 3.13: £1,000 Benefit Payment is Payable at the End of Year of Death /
Maturity to a Person Aged 30 and 60 years old, where n=20 years for Austria
Belgium, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.69 1.63 1.73 1.64
30 Endowment 36.89 36.84 36.90 36.87
Pure Endowment 35.19 35.21 35.16 35.22
Term Insurance 22.71 22.97 22.42 23.03
60 Endowment 46.20 46.69 46.12 46.72
Pure Endowment 23.48 23.72 23.70 23.69
Table 3.14: £1,000 Benefit Payment is Payable at the End of Year of Death /
Maturity to a Person Aged 30 and 60 years old, where n=20 years for Belgium
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France, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 2.12 1.98 2.10 1.94
30 Endowment 37.07 36.98 37.07 36.96
Pure Endowment 34.95 35.00 34.97 35.02
Term Insurance 20.14 20.59 20.17 20.74
60 Endowment 45.53 45.63 45.57 45.72
Pure Endowment 25.38 25.03 25.40 24.98
Table 3.15: £1,000 Benefit Payment is Payable at the End of Year of Death
/ Maturity to a Person Aged 30 and 60 years old, where n=20 years for France
Germany, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.62 1.54 1.60 1.54
30 Endowment 36.80 36.78 36.79 36.76
Pure Endowment 35.17 35.23 35.18 35.22
Term Insurance 23.08 23.76 23.10 23.71
60 Endowment 46.76 46.98 46.77 46.96
Pure Endowment 23.68 23.22 23.66 23.25
Table 3.16: £1,000 Benefit Payment is Payable at the End of Year of Death /
Maturity to a Person Aged 30 and 60 years old, where n=20 years for Germany
Greece, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.77 1.79 1.77 1.74
30 Endowment 36.93 36.94 36.93 36.93
Pure Endowment 35.15 35.14 35.15 35.19
Term Insurance 21.82 21.97 21.82 21.92
60 Endowment 45.85 46.17 45.85 46.15
Pure Endowment 24.03 24.20 24.03 24.22
Table 3.17: £1,000 Benefit Payment is Payable at the End of Year of Death
/ Maturity to a Person Aged 30 and 60 years old, where n=20 years for Greece
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Italy, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.21 1.19 1.31 1.16
30 Endowment 36.71 36.65 36.77 36.67
Pure Endowment 35.49 35.46 35.46 35.51
Term Insurance 20.26 19.83 20.07 20.10
60 Endowment 45.08 44.77 45.01 44.94
Pure Endowment 24.82 24.93 24.94 24.84
Table 3.18: £1,000 Benefit Payment is Payable at the End of Year of Death
/ Maturity to a Person Aged 30 and 60 years old, where n=20 years for Italy
Netherlands, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.06 1.00 1.09 1.05
30 Endowment 36.59 36.54 36.61 36.59
Pure Endowment 35.53 35.53 35.51 35.53
Term Insurance 22.68 22.38 22.20 22.21
60 Endowment 45.83 45.96 45.62 45.86
Pure Endowment 23.14 23.57 23.42 23.65
Table 3.19: £1,000 Benefit Payment is Payable at the End of Year of Death /
Maturity to a Person Aged 30 and 60 years old, where n=20 years for Nether-
lands
Portugal, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 2.56 2.41 2.59 2.26
30 Endowment 37.37 37.24 37.39 37.17
Pure Endowment 34.81 34.82 34.79 34.90
Term Insurance 23.54 23.79 23.26 24.41
60 Endowment 46.83 46.77 46.70 47.16
Pure Endowment 23.29 22.97 23.44 22.75
Table 3.20: £1,000 Benefit Payment is Payable at the End of Year of Death /
Maturity to a Person Aged 30 and 60 years old, where n=20 years for Portugal
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Spain, £
Age Insurance Type LC OL LC-GDP OL-GDP
Term Insurance 1.84 1.63 1.84 1.55
30 Endowment 36.99 36.86 36.99 36.80
Pure Endowment 35.15 35.22 35.15 35.24
Term Insurance 20.94 20.96 20.85 21.40
60 Endowment 45.62 45.53 45.59 45.84
Pure Endowment 24.68 24.57 24.73 24.44
Table 3.21: £1,000 Benefit Payment is Payable at the End of Year of Death
/ Maturity to a Person Aged 30 and 60 years old, where n=20 years for Spain
3.4 Actuarial Reserving
In the insurance context, actuarial reserve is the present value of the future cash
flows of an insurance policy and the total liability of the insurer is the sum of the
actuarial reserves for each individual policy. In better terms, actuarial reserve is
a liability equal to the actuarial present value (APV) of the future cash flows of a
contingent event.
Sufficient reserves are crucial for all regulated insurers as they are required to keep
aside reserves for managing future liabilities. Reserves play an important role in
assessing the financial condition of an insurer. Reserves are also important in
assessing the solvency of an insurer, in terms of its ability to meet its liabilities.
Moreover, reserves are also important in pricing the insurance products more ac-
curately. Actuaries price the insurance products by estimating the future cost of
claims on risks yet to be paid off to the insured by extrapolating the past paid
and reserved claim cost.
In this section, this study presents some results related to the calculation of the
actuarial reserve. Generally, the benefit reserve is the difference between the APV
of the insurance and the APV of future benefit premium at an annual rate of the
premiums. The general formula of the actuarial reserve is:
kVx = Ax+k − Pxa¨x+k (3.8)
The illustration of calculating the reserve is based on a 20–year endowment policy
for a person aged 30 years old, based on the Human Mortality Database of male
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populations for the selected Eurozone countries. The fitted mortality rates used
during the calculation process are based on 2007 data. Figure 3.23 presents the
mean percentage error of a k-year reserve of a 20-year endowment for a person
aged 30 years old. This study compares the MPE results among the four mortality
models, LC, OL, LC-GDP and OL-GDP.
Interestingly, this study observed different trends of reserve accumulations pre-
sented by each country. However, countries like Austria and Belgium pose quite
similar trends of reserves. Reserves for both countries are over-estimated by all
the four models, with the least error being presented by the new OL-GDP model.
Meanwhile, countries like France, Italy, Portugal and Spain behave similarly, with
notable under-estimation of reserves being observed from LC and LC-GDP models
conjointly. Anew, the model stands to provide the least error in estimating the
reserves. Greece and the Netherlands are being over-estimated at the beginning of
the policy inception and remain consistent in the middle of the tenure. MPE re-
sults for Germany are consistent for all four models. OL-GDP presents persistent
results starting at the 8th year of the term. Generally, it is notable that OL-GDP
presents the least error for all countries as compared to other mortality models.
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(a) Austria (b) Belgium
(c) France (d) Germany
(e) Greece (f) Italy
(g) Netherlands (h) Portugal
(i) Spain
Figure 3.23: Mean Percentage Error for a k-year Reserve for 20–year En-
dowment Policy for a Person Aged 30, based on Male Populations for nine
countries: Austria, Belgium, France, Germany, Greece, Italy, the Netherlands,
Portugal and Spain.
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3.5 Conclusion
In Section 2.4, this study developed a new model, OL-GDP, incorporating the GDP
factor into the existing model of O’Hare and Li (OL). In this chapter, this study
expands the investigation on the OL-GDP model, by examining its behaviour
towards variations of parameters involved in formulating the model. This study
conducts sensitivity analyses as part of assessing the impact of the model onto
the parameters variations. The analysis includes the variations of the age range,
varieties of correlation coefficients, different age parameters and also the variations
of the time-dependent factor of k2t .
In addition, this chapter further extends the study by looking at the impact of
the new model, OL-GDP from the financial perspective. Organisations like life
insurers and pension fund providers are sensitive towards the change of mortality
rates. Reflecting the variations and range of modifiable factors in the model, this
study observed that these have impacted the actuarial present values (APVs) of
the actuarial products. This study focuses its research on the basic products of life
insurance and annuity, namely annuity due, term insurance, pure endowment and
endowment insurance. Moreover, this study extends the investigation on actuarial
reserves as well.
For better understanding in demonstrating the good aspects of the new model,
OL-GDP, this study applied similar approach onto other mortality models of Lee
and Carter (LC), O’Hare and Li (OL) and Niu and Melenberg (LC-GDP) com-
paratively. As mortality experience is unique across countries, different mortality
models suit each country differently. However, in general, the new model, OL-
GDP suits best most of the countries and scenarios. As the impact of mortality
improvements is more significant to the insurers and pension fund providers, they
need to be more mindful and vigilant in choosing reliable mortality models. Future
investigation will certainly shed some light in mitigating the longevity risk.
Chapter 4
Hedging of Life Insurance and
Annuity Mortality Risks
Fundamentally, life insurance policies and annuity contracts have opposite finan-
cial goals. Life insurance provides financial aids to beneficiaries due to unexpected
or untimely death of the policyholder, while annuities provide a guaranteed stream
of income for life specially catered for old ages. In parallel, the liabilities value of
life insurance and annuity are also moving in opposite directions. The values of
the liabilities are more sensitive in response to a change in the underlying mor-
tality experience. In mitigating mortality risks, insurance and pension providers
may hedge the risk naturally as this type of hedging does not require any sophisti-
cated financial products like forwards or derivatives. The use of natural hedging is
seen to reduce the financial risks of those instruments. Through natural hedging,
the performance of both instruments will cancel each other out in stabilising the
aggregate liabilities of the cash flows.
This chapter provides empirical evidence that improvement of mortality rates will
impact the liabilities of life insurance and annuity portfolios. Technically, a de-
crease in mortality rates will have a negative impact on annuity liabilities whilst,
an increase in mortality rate will impact for the life insurance portfolio. For this
reason, insurers who are able to utilise natural hedging will have a competitive
advantage. This approach is internal to the insurance company, which makes it
more convenient and practical to implement by optimising the allocation of their
annuities and life insurance to hedge against longevity risk. Literally, this method
works well with a firm that writes both businesses, insurance and annuity. For
93
94
insurers that write a single line of business, either insurance or annuity, its only
portfolio of mortality risks is unlikely to provide an optimal mortality hedge.
4.1 Introduction
The moment when the aggregate change of mortality differs from that anticipated,
it provides a risk factor to both life insurance and annuities by affecting their fair
values, premiums and reserves. Relatively, the improvement of mortality from
expectations, will decrease a life insurer’s liabilities as the death benefit payments
will be payable later than expected. Contrarily, this will cause the annuity provider
to lose its relative advantage as they have to pay the annuity benefits longer than
expected. However, if the mortality deteriorates, the situation is otherwise. Life
insurers will face losses and annuity providers will have gains. In view of this,
natural hedging makes use of the interaction between life insurance and annuity
to balance out the liability outflows. The same changes of mortality experience
provides opposite impacts between both instruments, life insurance and annuity
(Cox and Lin, 2007).
The purpose of this chapter is to analyse the implementation of natural hedging
on mortality risks and to propose mortality securitisation as a tool to manage the
risks. Studies of natural hedging have been conducted earlier by many researchers
like (Cox and Lin, 2007; Wills and Sherris, 2010; Wang et al., 2010, 2013). Some
researchers studied the impact of mortality changes on life insurance (Marceau
and Gaillardetz, 1999) and annuities (Frees et al., 1996; Milevsky and Promislow,
2001) separately, or investigated the combination of bonds and other mortality
derivatives (Cairns et al., 2006a).
Marceau and Gaillardetz (1999) explored the reserves calculation in mortality and
interest rates environment of a life insurance portfolio for term life insurance and
pure endowment policies. On similar objective, Milevsky and Promislow (2001)
calculated the mortality-contingent claims, by modelling the future interest rate
risk. They observed that both mortality and interest rate risk can be hedged.
Subsequently, Wang et al. (2003) investigate the influence of changes in mortality
factors and propose an immunisation model to hedge against mortality risks. Wang
et al. (2013) investigate a natural hedging strategy and attempt to find an optimal
allocation of insurance products using experienced mortality rates rather than
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population mortality data. They consider both variance and mispricing effects of
longevity risk at the same time. According to Cox and Lin (2007), the insurance
price is negatively related to the degree of natural hedging and natural hedging is
an important factor contributing to the price difference among life insurers.
Heuristically, this chapter proposes mortality securitisation between capital mar-
ket investors and annuity issuers. In principle, it transfers the risk out of the
balance sheet or liabilities of the annuity issuer. This study investigates the im-
pact of mortality securitisation on annuity portfolio and, consequently, addresses
the issuers asset-liability management problem. If the annuity issuer manages to
hedge its mortality risk successfully, the product’s risk premium will be reduced,
subsequently lowering its prices. Hence, this will improve its competitiveness in
the market.
The rest of the chapter is organised as follows. Section 4.2, demonstrates the im-
pact of the risks related to mortality changes on life and annuity portfolio. Natural
hedging approach has been further illustrated to signify the idea of natural hedg-
ing and the needs for mortality securitisation, Section 4.3 analyse the economics of
mortality risk and execute the mortality securitisation. Section 4.4 proposes the
mortality securitisation framework for annuity portfolio and Section 4.5 concludes.
4.2 Risk of Mortality Change in Life and Annu-
ity Portfolio
This subchapter illustrates the concept of natural hedging. Natural hedging has
been widely undertaken by many companies. Companies are becoming increas-
ingly skillful at combing economic analysis of their business with financial manage-
ment. By exploiting the relationship between their earnings with their liabilities,
they can reduce their exposure to economic or financial risks. Natural hedging
is not only suitable for insurers and annuity providers, but it can be extensively
extended to any line of businesses. Even, the property companies undertake this
exercise in considering their business expansion. Since the property incomes and
property prices are strongly cyclical, the company is concerned to hedge the volatil-
ity of income during the economic downturn. The company will lose income on
existing cash-flow but gain from the lower cost of expansion. The application of
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natural hedging is more significant for companies that relate their business to-
wards the volatility of inflation and interest rates. Thus, this study focuses on the
application of natural hedging in the insurers and annuity providers.
Consider a portfolio of life contingent liabilities consisting of term life insurance
policies written on lives age 35 and immediate term life annuities written on lives
age 65. The ultimate outcome focuses on the insurer’s total liability should the
mortality improve or deteriorate. If the mortality improves, the insurer will have
loss on the annuity business and gain on the life insurance business. And if mortal-
ity declines, the effects are transposed. This study shows the effect on the insurer’s
liabilities if mortality risk increases or decreases as a result of a common shock. A
good shock refers to mortality improvement, while a bad shock refers to mortality
deterioration. In this subchapter, this study sets the shocks to be at ±(5%, 10%,
25% and 50%). Here are the assumptions:
1. Countries observed are Austria, Belgium, France, Germany, Greece, Italy,
the Netherlands, Portugal and Spain.
2. Term insurance for (35) and annuity for (65) are based on the 1960–2007
period using the OL-GDP Model. Exceptions are Germany and Greece
which start from 1970 and 1981 respectively.
3. For illustration purposes, the initial amount of the annual present value of
a 60-year term insurance on (35) is set at £100 for all countries.
4. Concurrently, the annual present value of a 30-year temporary annuity de-
rived from simultaneous equations is equivalent to £8,175, £7,979, £7,977,
£7,961, £8,043, £8,880, £8,610, £7,489 and £8,255 for Austria, Belgium,
France, Germany, Greece, Italy, the Netherlands, Portugal and Spain respec-
tively1 and is payable at the beginning of each year, where the first payment
is due at age 65.
5. Premium payments and annuity benefits are paid annually. Death benefits
are paid at the end of the year of death; death must occur within the n
years and the annuity is payable at the beginning of each year, as long as
the annuitant is alive or upon reaching age 95; whichever is earlier.
1By doing so, the liabilities of present values for both insurance benefits and annuity payments
arrived at about equal amount of £1,152.
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6. The mortality shock, ∈ is expressed as a percentage of the force of mortality
µx+t, ranges from -1 to 1, that is, -1 ≤ ∈ ≤ 1 with probability equal to
1. Without the shock, the survival probability for a life age (x) at year t
is px+t = exp(−µx+t). With the shock, the new survival probability p´x+t is
expressed as:
p´x+t = (e
−µx+t)1− = (px+t)1−
If the shock lies between 0 <  ≤ 1, mortality experience improves. On
the other hand, if the shock lies between -1 ≤  < 0, mortality experience
deteriorates.
7. The term structure for insurance is 60 years, issued to (35) and the term
structure for annuity is 30 years, issued to (65) respectively; and the effective
interest rate is flat; a single interest rate is used at i = 0.05 for both insurance
and annuity.
4.2.1 Expected Life Insurance Liabilities
For the term insurance, the present value of £1 paid at the end of the year of
death is υk and the expected present value is:
A1x:n =
n−1∑
k=0
vkkpxqx+k, (4.1)
where x is the age when the policy is issued (x = 35 in the analysis). For a benefit
of F the expected present value is FA1x:n .
The present value of £1 per year, paid at the beginning of the year until the year
of death or upon maturity, is:
a¨K(x:n )+1 =
1− υK(x:n )+1
d
(4.2)
The expected present value is:
a¨x:n = E
[
a¨K(x:n )+1
]
=
n−1∑
k=0
υkkpx (4.3)
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The net annual premium rate for £1 of benefit is determined so that the present
value of net premiums is equal to the present value of benefits. This means:
Px:n a¨x:n = A
1
x:n (4.4)
and for a benefit of F the annual premium is:
FPx:n =
FAx:n
a¨x:n
(4.5)
The insurer’s loss, L, is defined as the random variable of the present value of
benefits to be paid by the insurer less the annuity of premiums to be paid by
the insured (see (Bowers et al., 1997)). This relationship is known as Equivalence
Principle; under this principle, the expected loss is equal to zero;
E[L] = 0 (4.6)
This is then where the expected present value of future benefits equals the expected
present value of future premiums, E[PVFB] = E[PVFP]. In other words, at issue,
this is equal to:
APV (Future Premiums) = APV (Future Benefits) (4.7)
The contract of insurance is an agreement between the insurer and the insured.
The insurer agrees to pay for insurance benefits while in exchange, the insured
needs to pay the insurance premiums. Therefore, the insurer’s net random future
loss is defined by:
L = PV FB − PV FP (4.8)
where PVFB is the present value at time of issue, of future premiums to be paid
by the insured. For any paid premiums, P , the present value of the insurer’s net
loss if death occurs at time t is:
l(k) = vk − Pak (4.9)
Hence, the loss random variable, L corresponding to the loss function l(k) is:
L = l(K) = vK − PaK (4.10)
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In other words, if the insured dies at K(x : n) = t, then the insurer’s net loss is the
present value of the payment, less the present value premiums. For a £1 benefit,
the loss is:
L = υK(x:n )+1 − Px:n a¨K(x:n )+1 = υK(x:n )+1 − Px:n
1− υK(x:n )+1
d
(4.11)
It follows from the definition of the net premium Px:n that the expected loss is
zero. For a benefit of F , the loss is FL. In some cases, the loss can be negative
in which, this turned out to benefit the insurer. However, on average, the loss is
zero.
4.2.2 Expected Annuities Liabilities
For an annuitant (y), the present value of £1 per year paid at the beginning of
the year is
a¨K(y:n )+1 =
1− υK(y:n )+1
d
(4.12)
The expected present value
a¨y:n = E
[
a¨K(y:n )+1
]
=
n−1∑
k=0
υkkpy (4.13)
The policy is purchased with a single payment of a¨y:n for n term. In our example y
= 65 and the mortality table is based on annuity experience. For an annual benefit
of b, the net single premium is ba¨y:n . The company’s loss per unit of benefit is
a¨K(y:n )+1 − a¨y:n =
1
d
− a¨y:n − υ
K(y:n )+1
d
(4.14)
The expected loss is zero.
4.2.3 Liabilities of Term Life Insurance Portfolio
The portfolio has a term life insurance liability to pay a benefit of F at the end of
the year of the death of (x) before reaching age 95; and a liability to pay a benefit
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of b at the beginning of each year as long as (y) is alive or upon reaching age 95;
whichever is earlier. The total liability is
FυK(x:n )+1 + ba¨K(y:n )+1 (4.15)
To offset the liability the company has
FPxa¨K(x)+1 + ba¨y (4.16)
The difference is the total loss:
L = FυK(x)+1 + ba¨K(x)+1 − FPxa¨K(x)+1 + ba¨y (4.17)
The expected loss is zero. However, this expectation is calculated under the as-
sumption that mortality follows the life tables assumed in setting the premiums.
In the next subsection, impacts on the insurance and annuity present values are
presented with respect to mortality improvement or deterioration at certain level
of shock ranges between ±(5–50%).
4.2.4 Effects of Changes in Mortality to Life and Annuity
Payments
Tables 4.1 - 4.9 present the results of the present value of life insurance outflows
and annuity outflows at time t = 0 for all countries under study, separately and in
aggregate. They present the percentage deviation of the present value of benefits
from the life insurance premiums and that of annuity payments from the total
annuity premium collected at time t = 0. This study also shows the present value
of the sum of both life insurance and annuity payments and the percentage of
deviation from the present value of total premiums collected. Each result includes
a shock improvement (Panel A) or shock deterioration (Panel B) relative to the
mortality table, modelled by multiplying the force of mortality by a factor 1 – 
in each year.
As presented in Table 4.1 for Austria, with a small mortality improvement shock,
 = 0.10, the present value of the total annuity payments increases from £1,152
101
without shock to £1,170. In this scenario, annuity insurers will lose 1.57% [=
(1,170 – 1,152) / 1,152] of their expected total payments. In this scenario, life in-
surers will gain 5.49% of their expected total payments. If the above life insurance
and annuity are written by the same insurer, the shock has a much smaller effect
on its business (a 1.96% gain).
Whereas, at the mortality bad shock of  = –0.10, annuity insurers will gain 3.68%
[= (1,152 – 1,110) / 1,110] of their expected total payments. In this scenario,
life insurers will lose 5.06% of their expected total payments. If the above life
insurance and annuity are sold by the same insurer, a bad shock has little effect
on its business (a 0.69% loss). In a big good shock of 50%,  = 0.50, the present
value of total annuity payments will increase by 14.89% and the life insurer will
gain 33.94% of their total expected payments on average. The overall effects will
be 9.53% gain on a big good shock. Writing both life and annuity business, reduces
the impact of a big bad shock  = –0.50 to a 4.99% loss.
Interestingly for Belgium, the present value of liability outflows for annuity regis-
ters a marginal gain of 0.56% although the mortality rate has improved by a small
shock 5% ( = 0.05); see Table 4.2 for details. Hence, on aggregate, the insurer
experiences a gain of 1.61% from both life and annuity outflows following a small
shock mortality improvement of 5%.
On the other hand, a decrease of mortality rates by  = -0.05 and -0.10 generate an
aggregate gain of 0.31% and a loss of 0.30% respectively. Having said that, a major
bad shock in mortality rates by  = -0.50 has dragged the aggregate cash flow to
4.55% loss to the insurer. Comparing between the improvement and deterioration
of mortality rate, the former shows a greater impact to the insurer.
In France, as expected, a small shock of improvement of  = 0.05 and 0.10, results
in a great impact on both life and annuity’s present values. In addition, the
insurer experiences almost a natural hedging (near zero) in a small shock of  =
0.05, where the aggregate insurer’s outflows for both life and annuity are almost
balanced (-0.03%). Again, the insurer is still experiencing a natural hedging (less
than a gain of 1%) when the shock improved by  = 0.10. Notwithstanding, a big
shock ( = 0.50) gives the insurer a gain of 35.15% for life portfolio as compared
to a loss of 16.81% for annuity portfolio. Therefore, on aggregate, the insurer is
gaining 9.17% when the mortality rate registers a bigger improvement.
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Austria
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,121 -2.69 1,154 0.18 2,276 -1.25
=0.10 1,089 -5.49 1,170 1.57 2,259 -1.96
=0.25 982 -14.74 1,222 6.06 2,205 -4.34
=0.50 761 -33.94 1,324 14.89 2,085 -9.53
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.58 1,124 -2.44 2,306 0.07
= -0.10 1,211 5.06 1,110 -3.68 2,321 0.69
= -0.25 1,291 12.00 1,070 -7.15 2,360 2.42
= -0.50 1,408 22.23 1,011 -12.24 2,420 4.99
Table 4.1: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Austria
When the mortality rate deteriorates from  = 0.50 to  = 0.05, the present value
of life is increased from £1,184 to £1,426, bearing the loss to the insurer increases
by ten-fold from 2.73% to 23.72% (see Table 4.3). However, if the insurer also
underwrites the annuity portfolio, the loss can simply be reduced to 7.18%.
Similar experience is witnessed in Belgium, a small improvement by 5% ( = 0.05)
on mortality rate in Germany (see Table 4.4) provides gains for both life and an-
nuity’s present values. The gains are registered at £30 (reduced insurer’s liabilities
from £1,152 to £1,122) and £13 (£1,152 to £1,139) for life and annuity outflows
respectively. Accordingly, a small mortality improvement of 5% produces an ag-
gregate gain of 1.93% to the insurer. Important highlight is captured when the
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Belgium
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,122 -2.66 1,146 -0.56 2,268 -1.61
=0.10 1,090 -5.44 1,162 0.83 2,252 -2.30
=0.25 984 -14.59 1,214 5.34 2,198 -4.63
=0.50 765 -33.61 1,317 14.26 2,082 -9.68
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.55 1,116 -3.18 2,297 -0.31
= -0.10 1,210 5.01 1,101 -4.42 2,311 0.30
= -0.25 1,289 11.89 1,061 -7.89 2,351 2.00
= -0.50 1,407 22.06 1,003 -12.95 2,410 4.55
Table 4.2: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Belgium
mortality rate deteriorates even up to  = -0.10; the insurer’s aggregate outflows
between life and annuity are almost balanced (almost zero). However, the life and
annuity outflows start contradicting when mortality rate decreases by  = -0.25
and  = -0.50. The latter results in an aggregate loss of £94 [=£2,399 - £2,305]
or 4.11% to the insurer.
Table 4.5 below shows the impact of mortality changes to the present value of life
benefit and annuity payment for Greece. The small change of mortality rate by 
= 0.05 has reduced the present value of life benefits by £31 [=£1,152 - £1,121] or
-2.71% which means a gain to the insurer.
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France
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,120 -2.83 1,184 2.77 2,304 -0.03
=0.10 1,086 -5.78 1,200 4.11 2,285 -0.84
=0.25 974 -15.44 1,249 8.42 2,224 -3.51
=0.50 747 -35.15 1,346 16.81 2,093 -9.17
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,184 2.73 1,155 0.24 2,339 1.48
= -0.10 1,214 5.36 1,141 -0.97 2,355 2.20
= -0.25 1,299 12.75 1,102 -4.36 2,401 4.20
= -0.50 1,426 23.72 1,045 -9.35 2,470 7.18
Table 4.3: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of France
On aggregate the insurer loses 0.36%, 1.00%, 2.80% and 5.49% if the mortality
rates deteriorated by  = -0.05, -0.10, -0.25 and -0.50 respectively. Separately, a
small change of  = -0.05 gives loss of £30 [=£1,182 - £1,152] for life benefits and
an aggregate gain of £8 [=£2,313 - £2,305] to the insurer, if the insurer writes
both portfolio of life and annuity.
In Table 4.6, the results illustrate a similar pattern with earlier discussed coun-
tries like Austria and France, where an improvement of mortality rate has greater
impact as compared to deterioration of mortality regardless the magnitude of the
shock or . The insurer may not feel the impact even when the mortality rates
improved by up to 10%. However, at 5% mortality deterioration, the insurer may
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Germany
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,122 -2.66 1,139 -1.20 2,260 -1.93
=0.10 1,090 -5.43 1,155 0.21 2,244 -2.61
=0.25 984 -14.58 1,208 4.80 2,192 -4.89
=0.50 765 -33.62 1,312 13.86 2,077 -9.88
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.55 1,108 -3.86 2,290 -0.65
= -0.10 1,210 5.01 1,093 -5.12 2,303 -0.06
= -0.25 1,289 11.87 1,053 -8.64 2,342 1.61
= -0.50 1,406 21.99 994 -13.78 2,399 4.11
Table 4.4: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Germany
realise that the aggregate outflows will be experiencing a loss of £28 [=£2,333 -
£2,305].
One the other hand, it is interesting to note that, a decrease by 5% ( = -0.05)
in mortality rates for Italy will not give any impact to the annuity’s outflow as
its present value is closed to zero. Nevertheless, the insurer will lose about £14
[=£1,152 - £1,138] when the  = -0.10 for annuity portfolio.
Like Belgium and Germany, liability outflows for the Netherlands generate gains
for both life and annuity portfolio given  = 0.05, a small shock of mortality
improvement. The same for the aggregate outflows where insurer enjoys an excess
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Greece
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,121 -2.71 1,160 0.70 2,281 -1.01
=0.10 1,089 -5.53 1,176 2.06 2,265 -1.74
=0.25 981 -14.83 1,227 6.48 2,209 -4.17
=0.50 760 -34.05 1,327 15.19 2,087 -9.43
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.60 1,131 -1.88 2,313 0.36
= -0.10 1,211 5.11 1,117 -3.10 2,328 1.00
= -0.25 1,292 12.13 1,077 -6.52 2,369 2.80
= -0.50 1,412 22.52 1,019 -11.54 2,431 5.49
Table 4.5: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Greece
of £34 [=£2,305 - £2,271] or 1.45%. The same scenario of aggregate outflows
(almost zero) when mortality rate deteriorates by a small shock ( = -0.05).
Among all countries, changes of mortality rate have less impact on the Netherlands
for all rates of change or  as shown in Table 4.7. The most significant gain for life
and annuity are 32.60% and 12.50% respectively. Whereas, the maximum losses
are -20.64% for life benefits and -14.25% for annuity.
For Portugal, the insurer registers a positive outflow for both life and annuity
when  = 0.05 and 0.10; the aggregate present value for both are also increased
by £55 [=£2,305 - £2,250] and £71 [=£2,305 - £2,234]. Table 4.8 also shows a
gain of 1.06% and 0.43% when  reduced by 5% and 10% respectively.
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Italy
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,122 -2.64 1,180 2.41 2,302 -0.12
=0.10 1,090 -5.40 1,195 3.73 2,285 -0.84
=0.25 985 -14.54 1,245 8.00 2,229 -3.27
=0.50 764 -33.67 1,341 16.38 2,105 -8.64
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,181 2.53 1,151 -0.09 2,333 1.22
= -0.10 1,209 4.96 1,138 -1.28 2,347 1.84
= -0.25 1,287 11.72 1,099 -4.60 2,387 3.56
= -0.50 1,402 21.64 1,043 -9.48 2,445 6.08
Table 4.6: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Italy
Similar to Belgium, Germany and the Netherlands, an improvement of  = 0.05,
also provides a gain to the annuity portfolio. Moreover, an improvement of 
= 0.10 also generated a gain of £7 on the annuity’s present value. In addition,
among all countries, Portugal registers a maximum aggregate gain of 10.37% to
the insurer’s outflow for a major good shock of  = 0.50.
As for Spain, (please refer to Table 4.9), a major good shock of ( = 0.50) has
resulted in a maximum gain of 34.13% for life and a maximum loss of 15.67%
for annuity portfolio as compared to other countries under study. Interestingly,
a small shock of either  = 0.05 or -0.05 of mortality, generates almost balanced
aggregate present values (almost zero) for both life and annuity portfolios.
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Netherlands
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,123 -2.53 1,148 -0.38 2,271 -1.45
=0.10 1,093 -5.18 1,164 0.98 2,256 -2.10
=0.25 991 -13.97 1,215 5.42 2,206 -4.27
=0.50 777 -32.60 1,316 14.25 2,093 -9.17
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,180 2.42 1,118 -2.95 2,299 -0.27
= -0.10 1,207 4.74 1,104 -4.16 2,311 0.29
= -0.25 1,281 11.19 1,065 -7.56 2,347 1.82
= -0.50 1,390 20.64 1,008 -12.50 2,398 4.07
Table 4.7: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Netherlands
To summarise, mortality improvement has greater impact (huge gain for life’s out-
flow and severe loss for annuity’s outflow) as compared to mortality deterioration
for all countries (Austria, Belgium, France, Germany, Greece, Italy, the Nether-
lands, Portugal and Spain). Moreover, given the reality of longer life expectancy,
serious attention by insurers is required in managing longevity risk. This can be
done using natural hedging (Luciano et al., 2012) and capital markets (Kim and
Choi, 2011).
Natural hedging aims to stabilise the aggregate outflows of the company. This is
done through the interactions between life and annuity portfolio with respect to a
change in mortality (improvement or deterioration). Under these circumstances,
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Portugal
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,121 -2.71 1,129 -2.04 2,250 -2.38
=0.10 1,089 -5.54 1,145 -0.62 2,234 -3.08
=0.25 982 -14.81 1,199 4.01 2,180 -5.40
=0.50 761 -33.95 1,304 13.21 2,066 -10.37
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.61 1,098 -4.72 2,280 -1.06
= -0.10 1,211 5.12 1,083 -5.99 2,295 -0.43
= -0.25 1,293 12.18 1,043 -9.52 2,335 1.33
= -0.50 1,414 22.68 983 -14.66 2,397 4.01
Table 4.8: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Portugal
the insurer is expected to have a positive outflow for life benefits and negative
outflow for annuity payments during mortality improvement. And vice versa when
mortality rates are deteriorating. Based on that expectation, only Austria, France,
Greece, Italy and Spain experience the expected patterns for both life and annuity
portfolio as well as on an aggregate basis.
On the other hand, Belgium, Germany, the Netherlands and Portugal interestingly
record a positive impact for both life and annuity at  = 0.05. Further observa-
tions on mortality rates for all countries show that the truncation during ages
87–89 has affected both life and annuity liabilities for countries like Belgium, Ger-
many, France, the Netherlands and Portugal (see Appendix II for details). Hence,
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Spain
Panel A: Improvement level aged (35) / Improvement level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
=0.05 1,121 -2.71 1,167 1.31 2,288 -0.70
=0.10 1,089 -5.54 1,183 2.66 2,272 -1.44
=0.25 981 -14.85 1,234 7.05 2,215 -3.90
=0.50 759 -34.13 1,333 15.67 2,092 -9.23
Panel B: Deterioration level aged (35) / Deterioration level aged (65) = 1
Present Value 4 Present Value 4 Total 4
Life Benefits Life, Annuity Annuity, Present Total,
Payments, £ % Payments, £ % Value, £ %
=0 1,152 - 1,152 - 2,305 -
= -0.05 1,182 2.60 1,138 -1.26 2,320 0.67
= -0.10 1,211 5.11 1,124 -2.48 2,335 1.32
= -0.25 1,292 12.12 1,084 -5.89 2,376 3.11
= -0.50 1,411 22.47 1,027 -10.90 2,438 5.78
Table 4.9: Results for 5%, 10%, 25% and 50% Mortality Improvement or
Deterioration Relative to Life and Annuity Mortality Tables (the present values
are in thousands) of Spain
improvements in mortality rates enforce serious concerns to insurers not only for
annuity liabilities but on both life and annuity liabilities for some countries when
mortality rate improves. A securitisation of longevity risk through capital market
solutions can be another approach towards risk management.
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4.3 Economics of Mortality Risk and Securitisa-
tion
This subsection describes the urgency to attend to the longevity risk. This phe-
nomenon has alarmed annuity providers as to how they manage the longevity risk
efficiently. Historically, life securitisation transactions began in the late twentieth
century (end-1990/early-2000). Although they can be considered as relatively as
new, these insurance-related securities have become famous after the global finan-
cial crisis in 2008. Securitisations can be classified into two categories; securities
backed by an asset like corporate bonds or mortgages (asset-backed securities) and
securities not backed by an asset like futures, options and swaps (non-asset-backed
securities).
4.3.1 Changes in Mortality Experience
Over the past few decades, the world has been experiencing an unprecedented
increase in life expectancy globally (Macdonald et al., 1998). This phenomenon
has benefited the individuals, but at the same time has threatened the annuity
providers. Annuity providers often look for effective tools and measures in ad-
dressing this issue. Viably, they may consider using financial markets to mitigate
the longevity risk by securitising parts of their portfolio. Securitisation acts as a
hedge for the insurer’s portfolio by transferring the risks of the portfolio to third
parties and serves as a substitute for reinsurance (Lorson and Wagner, 2014).
Unlike the non-life segments, where securitisation transactions like catastrophic
bonds were introduced long time ago, the life securitisation market is still at an
infancy at age (Deutsche Bank, 2010). To draw on history, the first mortality-
linked securitisation transaction was carried out by the world’s second largest
reinsurer, Swiss Re in 2003. The issue of the Vita Capital bond reduced Swiss
Re’s exposure on longevity risk. The principal payments of this bond were based
on a predefined mortality index (Blake et al., 2006). Another attempt of longevity
bond issuance was made by the European Investment Bank in 2004. The bond
with coupon payment depending on the survival of English and Welsh males aged
65 years has a contract duration of 25 years. However, this £540 million worth
volume did not attract enough investors and was abandoned in 2005 (Chen and
Cummins, 2010). After these initial attempts, the life securitisation market has
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flooded the industry with increased volumes and transactions until 2007. During
the recent financial crisis, the issuing of life securitisations dropped and now is
still in a recovery phase.
Numerous studies have been conducted earlier on hedging the longevity risk. Wang
et al. (2011) applied the concept of reverse mortgages to hedge longevity risk
for life insurance companies. Alternatively, various other methods of hedging
longevity risk have been demonstrated by many researchers. Among others, Delta-
Gamma hedging (Luciano et al., 2012), natural hedging (Gatzert and Wesker,
2012; Wang et al., 2010) and annuity securitisation (Kim and Choi, 2011). Utilising
the percentile tranching approach, Kim and Choi (2011) applied the concept of
an inverse survivor bond to a fictional portfolio of Australian annuity contracts.
They assumed that by investing in this bond, investors can achieve their targeted
yield.
This subchapter aims to review and analyse the previous studies related to hedging
longevity risk. Main discussion of this subchapter would be focused on the study
conducted by Kim and Choi (2011) and Lorson and Wagner (2014). They applied
a percentile tranching method in their study. The chosen percentiles are then
linked directly to Standard & Poor’s (S&P)2 rating classes, so that the quality
of the securitisation tranche become transparent to the investors. Besides that,
the issuer also has an opportunity to approach specific investors based on their
risk-appetite towards the securitisation offer.
Subsequently, for future research, this study aims to extend the methods of hedg-
ing the longevity risk on the annuity portfolio. This can be done through annuity
securitisation. Motivated by Lorson and Wagner (2014), this study will employ a
similar concept. However, this study utilises the OL-GDP mortality model and
focuses on nine selected Eurozone countries namely Austria, Belgium, France,
Germany, Greece, Italy, the Netherlands, Portugal and Spain. The calculation
of the bond price is done in a three-step process. First step is the calculation of
future mortality rates using the OL-GDP model. In the second step, the fore-
casted annuity portfolio is segregated into different tranches with the help of the
percentile tranching method as per Kim and Choi (2011). Hence, attachment and
2Standard & Poor’s Global Ratings is an American financial services company that has been
operating for more than 150 years. They are the world’s leading provider of credit ratings. They
educate the market participants in making investment decisions confidently.
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detachment points are applied on the individual tranches based on the S&P rat-
ings for insurance-linked securities. Finally, based on classical bond pricing, the
pricing of each tranche of the annuity securitisation is computed. The principal
payments that investors receive depend on the survival distribution of the under-
lying portfolio randomly. The higher the number of actual survivors compared at
to expectations, the lower the amount of the principal payment.
4.3.2 Longevity Bonds
Longevity bonds are used by insurance companies to hedge their annuity portfolio
against mortality changes. The structure of this bond is illustrated in Figure 4.1.
In the middle of the bond structure stands a special-purpose vehicle (SPV). This
legal entity acts as an inter-mediator that brings together the issuer (the insurance
company) and the investors who want to engage in the annuity portfolio. From
the insurer’s viewpoint, he is paying out the annuities to its annuitants, while at
the same time transferring the premiums received from the annuity sales to the
SPV. Meanwhile, from the investor’s viewpoint, through the investment investors
make into the bonds, they receive the coupon payments and principal from the
SPV. Being the intermediary, SPV provides contingent payments to the insurance
company (securing thus the annuity payments) and issues a survivor bond which
pays regular coupon payments to the investors. Normally, the principal is paid
as a lump sum at the maturity of the bond, while the coupon payment is paid
annually and subject to the survival rate of the underlying portfolio, and thus it
is exposed to risk. In this study, the principal payment will be at risk, whereas
the coupon payments are secured.
Figure 4.1: Structure of a Longevity Bond
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In attracting more investors, the longevity bond is divided into several different
tranches. Each number of tranche carries different weights of risk. The investors
in the first tranche are the first to lose their coupon or principal payments if the
number of actual survivors in the portfolio is higher than expected. Next, the loss
goes to the second tranche if the first tranche is exceeded, and the process goes
on. Different tranches pose different characteristics of risk and different prices for
the bond.
4.4 Securitisation Framework for Annuity Port-
folio
This section describes the proposed bond structure as a way to securitise a life
annuity portfolio. This may help insurers to face longevity risk within their annuity
portfolios. The process of designing the bond must be well structured, scrutinised
and prudent. Fundamentally, the process of pricing the bond involves:
1. Forecasting future mortality rates
2. Tranching process and excess loss
3. Pricing of bond
4.4.1 Forecasting Mortality Rates with OL-GDP Model
The evolution of mortality models was pioneered by Lee and Carter (1992). Since
then, a wide range of stochastic models for forecasting mortality rates have been
developed extensively in the last decade. Although, the Lee-Carter model is still
being the most popular model and widely used in the literature for valuing life
portfolios and as a basis for insurance securitisation (Denuit et al., 2007; Kim and
Choi, 2011), this study applies the improved mortality model with GDP effect,
OL-GDP as presented in Chapter 2.
Applying the OL-GDP model requires a two-step process. First, the model pa-
rameters in Equation 2.7 are estimated based on the observed mortality rates and,
second, the projections for the future are performed.
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The time-dependent factors of OL-GDP are forecasted using the Arima function
from R package forecast, ”forecast.Arima”.
4.4.2 Tranching Process and Excess Loss
Many studies conducted earlier (Wang, 2000; Wills and Sherris, 2010; Kim and
Choi, 2011; Lorson and Wagner, 2014), applied the tranching approach in pricing
the bond. The definition of the individual tranches to be securitised varies. For
instance, Kim and Choi (2011) defined the attachment point of the first tranche
at the median survival probability, whilst Lorson and Wagner (2014) linked the
attachment point to the S&P default table for insurance-linked securities3 (please
see Appendix 1). This subsection undertakes the definition of individual tranches
to be securitised and the calculation of the excess loss for each tranche. Inspired by
Lorson and Wagner (2014), this study adopts a similar approach in defining the
tranche by considering N as different tranches in the proposed longevity bond.
The attachment points p
(j−1)
x,t and detachment points p
(j)
x,t for tranche j, where
j = 1, 2, · · · , N , are defined as a percentile of the cumulative forecasted survival
distribution. In this approach, the detachment point of the last tranche is defined
as the 100th percentile of the survival distribution, i.e. p
(N)
x,t = 1(100 percentile).
This study assumes that the attachment and detachment points for the remaining
tranches are flexible and defined according to the intended tranche composition of
the securitisation. The percentile below the attachment point of the first tranche
p
(0)
x is the part retained by the issuer. This can be considered as a first loss position.
Subsequently, the percentile within the attachment and detachment points will be
borne by the investors in Tranche j.
In calculating the excess loss for each tranche, this study assumes the insurer pays
£1 to each annuitant. Consider the attachment points p
(j−1)
x,t and the detachment
points p
(j)
x,t for each tranche j, where j = 1, 2, · · · , N are given, and let lx represent
the initial population of annuitants of age x at the beginning of the securitisation
(t = 0); thus, the actual number of survivors in each group (tranche) is a random
variable of survival distribution rates, px,t, where lx+t = lx · px,t, describes the
actual number of survivors at age (x + t). As described in Figure 4.2, each dot
3S&P provides cumulative default probabilities for different rating classes and different matu-
rities. In Appendix I, this study reports the S&P cumulative default probabilities for insurance-
linked securitisations corresponding to the rating classes AAA to B– and maturities ranging from
T = 1 to 30 years.
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represents one realisation of the life expectancy simulation for individual ages x at
a given time t after securitisation. The dashed lines indicate the attachment and
detachment points of the observed tranche j (at time t). If a survival realisation
lies within the compound of the loss (between the dashed lines), then, the tranche
j has to bear the loss. The loss for tranche j is triggered by the grey shade. Thus,
the random variable of the excess loss for the jth tranche for individuals aged x
at the time of securitisation and t years after securitisation, can be described by:
L
(j)
x+t = [Lx+t − L(j−1)x+t ]+ − [Lx+t − L(j)x+t]+ (4.18)
where, [ ∗ ]+ stands for max (0,∗).
Figure 4.2: Illustration of the Excess Loss L
(j)
x+t Calculation [see Equation 4.18]
for Tranche j at Time t for Annuitants Aged x+ t (age x at the time of securi-
tisation)
4.4.3 Pricing of Longevity Bond
Having determined the excess loss that may be incurred during the tranching
process, the next step is to price the bond appropriately. In this practice, if the
number of survivors is higher than expected, the tranche will be triggered; then
the principal payment of this tranche is reduced proportionally. The proportional
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default factor for each tranche j and time t is defined by:
Λ
(j)
x+t =
L
(j)
x+t
l
(j)
x+t − l(j−1)x+t
(4.19)
where, 0 ≤ Λ(j)x+t ≤ 1.
The process involved in pricing the single tranche and the annuity securitisation
of a longevity bond consists of two parts, the principal payment and the coupon
payment.
The structure of the bond is designed so as to allow the back payment of the
nominal FV to be distributed over the duration of the contract T with T being
an equal size of payments which is defined by FV/T . Since the principal payment
is linked to risk, the random variable of this is:
P
(j)
x+t = (1− Λ(j)x+t) ·
FV
T
(4.20)
for the tranches j = 1, 2, · · · , N and the annuitants ages x + t(t = 1, 2, · · · , T ).
The principal value can vary between 0 (where the actual survival rate is greater
than the detachment points of the jth tranche) and FV/T (a full payment of
where the actual survival rate is lower than the corresponding attachment point
of the jth tranche). In other words, 0 ≤ P˜(j)x+t ≤ FV/T .
On another part, the coupon payment is being paid annually based on the out-
standing principal. Normally, the annual interest rate, c(j) applied to each tranche,
j, comprises of a benchmark yield, y set by LIBOR or EURIBOR for instance,
plus a tranche-specific spread, s(j);
c(j) = y + s(j) (4.21)
As the calculation of the interest amount is defined by the outstanding amount of
debt toward the investor;
Dt = FV − (t− 1) · FV/T = (T − t+ 1) · FV/T (4.22)
118
Thus, the coupon payment is given by:
C
(j)
t = Dt · c(j) = (T − t+ 1) ·
FV
T
· (y + s(j)) (4.23)
for all tranches j = 1, 2, · · · , N in times t = 1, 2, · · · , T .
Finally, the price of the longevity bond is derived by adding the components of
principal payment and coupon payment. The securities price P
(j)
x , in time t = 0 for
individual age x (at the time of securitisation) and for tranches, j = 1, 2, · · · , N ,
corresponds to the present value of the sum of principal payments, P
(j),P
x and the
sum of all discounted coupon, P
(j),C
x payments until contract maturity, T . The
present value of the bond price, P
(j)
x is:
P (j)x = P
(j),P
x + P
(j),C
x
=
T∑
t=1
E(P˜
(j)
x+t · (1 + rf )−t +
T∑
t=1
C
(j)
t · (1 + rf )−1
=
T∑
t=1
=
1
(1 + rf )t
· [E(P˜(j)x+t) + C(j)t ]
=
FV
T
·
T∑
t=1
· 1
(1 + rf )t
· [E(1− Λ˜(j)x+t) + (T − t+ 1) · (y + s(j)]
(4.24)
with rf denoting the risk-free interest rate and E(∗) denotes the expected value
operator.
4.5 Conclusion
Longevity risk has long been an issue for insurance companies and also annuity
and pension providers. There are numerous ways being used as alternative risk
transfers. Among others are reinsurance, natural hedging or transferring the risk
to the capital market through bond issuance, swaps and options. This study
introduces a natural hedging to hedge the longevity risk. Natural hedging utilises
the interaction between life insurance and annuities that observe the change of
mortality as a way to stabilise the company’s cash outflows. Through the empirical
evidence, this study suggests that natural hedging is an important factor that
contributes to the difference of the annuity price after managing other variables.
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On another section, this study proposed a framework for annuity securitisation
through the introduction of a longevity bond. Through the forecasted mortality
rates and the tranching process, a longevity bond is then priced appropriately.
This approach is in line with the government’s concern on longevity risk. In
addressing this issue, regulators have developed risk-based capital regimes that
prompts the market players like insurers to consider the business mix which allow
them to optimise the management and allocation of their capital. Under this
regime, all market players can choose either to acquire annuity and longevity risk
(by offering a niche longevity instrument like bond) or to reduce their exposure
due to uncertainty of future mortality improvements by abiding to the minimum
future capital requirements that has been set by the regulator at the same time.
Chapter 5
Conclusion
This study has shown that the growth of ageing population is evident as a positive
milestone of society’s well-being. Many factors contribute to human longevity,
its macroeconomic factors affecting it the most. Having said that, each country
experiences a different trend of longevity improvement. For instance, the life
expectancy for European countries has risen significantly over the past few decades.
This has led insurance and pension providers to revisit their ways of pricing their
products and of hedging longevity risk. Hence, this study has addressed this
concern by developing a robust mortality model. In achieving it, the new model
has improved the existing O’Hare and Li (OL) model and has considered the
influence of gross domestic product (GDP) into the new model. Therefore, the
development of the new mortality model through the combination of the OL model
and GDP-age dependent factor has increased the predictive power as compared to
other mortality models.
Economic growth and health status are two major factors being deeply studied in
gauging nations’ social development and public policy. Due to these facts, socio-
economic factors such as GDP, inflation and unemployment have clearly been
observed to have a causal effect on mortality experience. The majority of related
studies showed that improvements in mortality have been accompanied by growth
in GDP. Hence, this study has found that the mortality rate and GDP growth are
highly correlated in the countries sampled (Austria, Belgium,France, Germany,
Greece, Italy, the Netherlands, Portugal and Spain). Moreover, the mortality of
GDP relationship has been found to be more significant for older ages regardless
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of gender of which this age group is the most significant group that exposed timely
to the longevity risk.
Following this, a new GDP-age dependent model has been introduced by assessing
the role of economic growth on mortality dynamics. As shown in the equation
below, the additional factor, cgx is a vector of correlation coefficients between
logarithmic of GDP per capita and mortality rates for ages 0–89:
ln(mx,t) = b
1
x + k
1
t + cgx(x¯− x)k2t + (x¯− x)+k3t + ([x¯− x]+)2k4t + γt−x + x,t
where factor b1x describes the average age-specific mortality, that ensures the basic
shape of the mortality curve over ages is in line with historical observations; factor
k1t represents the changes in the mortality level; whilst k
2
t factor allows changes in
mortality to vary between ages reflecting the historical observations that improve-
ment rates can differ for different age classes; k3t and k
4
t model the effects specific
to the lower ages; γt−x models the cohort effect, (x¯− x)+ = max(x¯− x, 0); and x¯
is the average of age considered.
This study validates the performance of the proposed model, OL-GDP against
other mortality models, i.e. LC, OL and LC-GDP through several measures and
approaches. Evidently, with the inclusion of the GDP growth indicator in the OL-
GDP model, this study finds the best fitting model for most Eurozone countries,
especially for France, Germany and Italy. Except for female, male and unisex
produced the best fitting of OL-GDP compared to other models. This study notes
the impact of GDP is significant especially for the most populous on sample coun-
tries. What is more, OL-GDP model also demonstrates better quality forecasts
of mortality rates. Essentially, the forecasting shows significant improvement in
forecasting results for shorter (5 years) and longer (15 years) periods of times in
comparison to the LC model which acts as the reference model. The impact of
economic growth on mortality dynamics has proved to be noteworthy.
Second, in validating the model’s robustness and intuitiveness, this study has
proved that the OL-GDP model responds well to the parameters variations com-
pared to alternative models. Sensitivity analyses was conducted in assessing the
impact of the model onto the parameters variations. The analysis includes the
variations of the age range used, varieties of correlation coefficients, different age
parameters and also the variations of the time-dependent factor of k2t . In addition,
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this study has shown that the model also responds well from a financial perspec-
tive. Organisations like life insurers and pension funds are sensitive towards the
change of mortality rates. Drawing on the variations and range of modifiable
factors in the model, this study observes that these variations have impacted
the actuarial present values (APVs) of the actuarial products. In reference, this
study has focused the research on the basic products of life insurance and annuity,
namely annuity due, term insurance, pure endowment and endowment insurance.
Moreover, this study has extended the investigation to actuarial reserves as well.
For better understanding, this study has conducted similar studies on other mor-
tality models like Lee and Carter (LC), O’Hare and Li (OL) and Niu and Melenberg
(LC-GDP). As mortality experience is unique across countries, different mortality
models suit each country differently. However, in general, the OL-GDP model
suits best most countries and scenarios. As the impact of mortality improvements
is more significant to the insurers and pension fund providers, they need to be
more mindful and vigilant in choosing reliable mortality models. A suitable choice
of mortality models is deemed crucial. Further investigation in the future will
certainly shed some light on longevity risk.
Third, this study has further investigated further the risk of mortality rate changes.
The ultimate outcome focuses on the insurer’s total liability should the mortality
improve or deteriorate. If the mortality improves, the insurer will have a loss on
the annuity business and a gain on the life insurance business. And if mortality
declines, the effects are transposed. This study has shown the effect on the insurer’s
liabilities if the mortality risk increases or decreases as a result of a common
shock. A good shock refers to mortality improvement, while a bad shock refers
to mortality deterioration. Therefore, this study has illustrated that mortality
improvement has greater impact (huge gain for life’s cash flow and severe loss
for annuity’s cash flow) as compared to mortality deterioration for all countries
(Austria, Belgium, France, Germany, Greece, Italy, the Netherlands, Portugal and
Spain). Moreover, given the reality of longer life expectancy, serious attention by
insurers is required when managing longevity risk. This can be done using natural
hedging (Luciano et al., 2012) and capital markets (Kim and Choi, 2011).
Fourth, in reference to the concern of risk of mortality rate changes, this study has
introduced a framework for an annuity securitisation with the help of longevity
bond. At the same time, this study has taken the perspective of the annuity issuer
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and calculated the price of hedging for the company. The proposed framework ap-
plied a tranching approach for the securitisation based on the percentile tranching
method and designed the bond in a way that the principal payments are risky,
i.e. depend on the survival rates of the underlying portfolio of annuitants. To do
so, the proposed framework first used the OL-GDP model for European countries
and calculated estimates of future mortality rates. Next, the tranching process is
done by segregating the portfolio into different rated tranches according to differ-
ent risk profiles based on the S&P ratings for insurance-linked securities. Finally,
the proposed framework determines the price of the longevity bond for hedging
the contracts against longevity risk.
With that, this study foresees that, considering the importance of having a robust
mortality model on forecasting, pricing, reserving and managing insurance liabili-
ties, OL-GDP model can be an alternative model for insurers and pension providers
in pricing their products and managing their cash flows efficiently. Therefore, OL-
GDP model helps insurers to price life insurance better and allocate sufficient
insurance reserve safe. Moreover, OL-GDP model helps examine mortality and
longevity risks in a more prudent manner.
Although the new model is able to estimate the historical trends in mortality data
efficiently, the estimation may not always be a sensible procedure to employ in
the long-run and across the globe. Perhaps, as mentioned earlier, different coun-
tries experience different pace of economic growth, emerging and frontier markets
tend to enjoy higher GDP growth rates on average, compared to their developed
counterparts. Moreover, as the mortality in the Eurozone countries has not always
declined along the path represented by the plot of k, this will reach to the impos-
sibly high levels of mortality rates eventually. Thus, this will disrupt the accuracy
of the mortality estimations. Perhaps the institutional bodies doing the demo-
graphics research may produce some insights that the twentieth-century trends
will continue in the future. Therefore, further investigation on this will certainly
shed some light on mortality studies. An in-depth study on this subject will abso-
lutely give a clearer picture in explaining the mortality trends more precisely. At
the same time, this will definitely improve the mortality forecasting accuracy.
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There are rooms for extending this study’s scope. Future studies may work on the
OL-GDP model to explore various ways of managing mortality and longevity risks.
This can be done by implementing the natural hedging strategy or structuring cap-
ital market solutions (securitisation and financial derivatives) for efficient liabilities
outflow management or optimal securities/derivatives pricing respectively.
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Appendix I
S&P default table for insurance-linked securitisations reporting cumu-
lative default probabilities (in %) for different ratings and maturities
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Appendix II
Mortality Rate based on OL-GDP Model for Austria, Belgium, France,
Germany, Greece, Italy, Netherlands,Portugal and Spain
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